Statistical Methods for Constructing Heterogeneous Biomarker Networks by Xie, Shanghong
Statistical Methods for Constructing Heterogeneous
Biomarker Networks
Shanghong Xie
Submitted in partial fulfillment of the
requirements for the degree of
Doctor of Philosophy
under the Executive Committe







Statistical Methods for Constructing Heterogeneous
Biomarker Networks
Shanghong Xie
The theme of this dissertation is to construct heterogeneous biomarker networks using graphi-
cal models for understanding disease progression and prognosis. Biomarkers may organize into
networks of connected regions. Substantial heterogeneity in networks between individuals and sub-
groups of individuals is observed. The strengths of network connections may vary across subjects
depending on subject-specific covariates (e.g., genetic variants, age). In addition, the connectivities
between biomarkers, as subject-specific network features, have been found to predict disease clinical
outcomes. Thus, it is important to accurately identify biomarker network structure and estimate
the strength of connections.
Graphical models have been extensively used to construct complex networks. However, the
estimated networks are at the population level, not accounting for subjects’ covariates. More flex-
ible covariate-dependent graphical models are needed to capture the heterogeneity in subjects and
further create new network features to improve prediction of disease clinical outcomes and stratify
subjects into clinically meaningful groups. A large number of parameters are required in covariate-
dependent graphical models. Regularization needs to be imposed to handle the high-dimensional
parameter space. Furthermore, personalized clinical symptom networks can be constructed to in-
vestigate co-occurrence of clinical symptoms. When there are multiple biomarker modalities, the
estimation of a target biomarker network can be improved by incorporating prior network infor-
mation from the external modality. This dissertation contains four parts to achieve these goals:
(1) An efficient `0-norm feature selection method based on augmented and penalized minimization
to tackle the high-dimensional parameter space involved in covariate-dependent graphical models;
(2) A two-stage approach to identify disease-associated biomarker network features; (3) An appli-
cation to construct personalized symptom networks; (4) A node-wise biomarker graphical model
to leverage the shared mechanism between multi-modality data when external modality data is
available.
In the first part of the dissertation, we propose a two-stage procedure to regularize `0-norm as
close as possible and solve it by a highly efficient and simple computational algorithm. Advances
in high-throughput technologies in genomics and imaging yield unprecedentedly large numbers of
prognostic biomarkers. To accommodate the scale of biomarkers and study their association with
disease outcomes, penalized regression is often used to identify important biomarkers. The ideal
variable selection procedure would search for the best subset of predictors, which is equivalent to
imposing an `0-penalty on the regression coefficients. Since this optimization is a non-deterministic
polynomial-time hard (NP-hard) problem that does not scale with number of biomarkers, alter-
native methods mostly place smooth penalties on the regression parameters, which lead to com-
putationally feasible optimization problems. However, empirical studies and theoretical analyses
show that convex approximation of `0-norm (e.g., `1) does not outperform their `0 counterpart.
The progress for `0-norm feature selection is relatively slower, where the main methods are greedy
algorithms such as stepwise regression or orthogonal matching pursuit. Penalized regression based
on regularizing `0-norm remains much less explored in the literature. In this work, inspired by the
recently popular augmenting and data splitting algorithms including alternating direction method
of multipliers, we propose a two-stage procedure for `0-penalty variable selection, referred to as
augmented penalized minimization-L0 (APM-L0). APM-L0 targets `0-norm as closely as possible
while keeping computation tractable, efficient, and simple, which is achieved by iterating between
a convex regularized regression and a simple hard-thresholding estimation. The procedure can be
viewed as arising from regularized optimization with truncated `1 norm. Thus, we propose to treat
regularization parameter and thresholding parameter as tuning parameters and select based on
cross-validation. A one-step coordinate descent algorithm is used in the first stage to significantly
improve computational efficiency. Through extensive simulation studies and real data applica-
tion, we demonstrate superior performance of the proposed method in terms of selection accuracy
and computational speed as compared to existing methods. The proposed APM-L0 procedure is
implemented in the R-package APML0.
In the second part of the dissertation, we develop a two-stage method to estimate biomarker
networks that account for heterogeneity among subjects and evaluate the network’s association with
disease clinical outcome. In the first stage, we propose a conditional Gaussian graphical model with
mean and precision matrix depending on covariates to obtain subject- or subgroup-specific networks.
In the second stage, we evaluate the clinical utility of network measures (connection strengths)
estimated from the first stage. The second stage analysis provides the relative predictive power
of between-region network measures on clinical impairment in the context of regional biomarkers
and existing disease risk factors. We assess the performance of the proposed method by extensive
simulation studies and application to a Huntington’s disease (HD) study to investigate the effect
of HD causal gene on the rate of change in motor symptom through affecting brain subcortical
and cortical grey matter atrophy connections. We show that cortical network connections and
subcortical volumes, but not subcortical connections are identified to be predictive of clinical motor
function deterioration. We validate these findings in an independent HD study. Lastly, highly
similar patterns seen in the grey matter connections and a previous white matter connectivity
study suggest a shared biological mechanism for HD and support the hypothesis that white matter
loss is a direct result of neuronal loss as opposed to the loss of myelin or dysmyelination.
In the third part of the dissertation, we apply the methodology to construct heterogeneous
cross-sectional symptom networks. The co-occurrence of symptoms may result from the direct
interactions between these symptoms and the symptoms can be treated as a system. In addition,
subject-specific risk factors (e.g., genetic variants, age) can also exert external influence on the
system. In this work, we develop a covariate-dependent conditional Gaussian graphical model to
obtain personalized symptom networks. The strengths of network connections are modeled as a
function of covariates to capture the heterogeneity among individuals and subgroups of individuals.
We assess the performance of the proposed method by simulation studies and an application to a
Huntington’s disease study to investigate the networks of symptoms in different domains (motor,
cognitive, psychiatric) and identify the important brain imaging biomarkers associated with the
connections. We show that the symptoms in the same domain interact more often with each other
than across domains. We validate the findings using subjects’ measurements from follow-up visits.
In the fourth part of the dissertation, we propose an integrative learning approach to improve
the estimation of subject-specific networks of target modality when external modality data is avail-
able. The biomarker networks measured by different modalities of data (e.g., structural magnetic
resonance imaging (sMRI), diffusion tensor imaging (DTI)) may share the same true underlying
biological mechanism. In this work, we propose a node-wise biomarker graphical model to leverage
the shared mechanism between multi-modality data to provide a more reliable estimation of the
target modality network and account for the heterogeneity in networks due to differences between
subjects and networks of external modality. Latent variables are introduced to represent the shared
unobserved biological network and the information from the external modality is incorporated to
model the distribution of the underlying biological network. An approximation approach is used
to calculate the posterior expectations of latent variables to reduce time. The performance of the
proposed method is demonstrated by extensive simulation studies and an application to construct
gray matter brain atrophy network of Huntington’s disease by using sMRI data and DTI data. The
estimated network measures are shown to be meaningful for predicting follow-up clinical outcomes
in terms of patient stratification and prediction.
Lastly, we conclude the dissertation with comments on limitations and extensions.
Key Words: Graphical Model; Regularized Regression; Mediation Analysis; Variable Selection;
ADMM; `0-Penalty; Structural Co-variance Network; Multi-modality Data; Symptom Network;
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Chapter 1
Background and Overview
Brain atrophy has been shown to begin decades before the presence of notable clinical symptoms of
neurodegenerative diseases (Tabrizi et al., 2009). Several studies have evaluated regional morpho-
logical changes occurring in the cerebral cortex (e.g., cortical thinning and volume loss) and have
provided evidence of early cortical thinning as one of the hallmarks of disease (e.g., Huntington’s
disease (HD); Rosas et al., 2005, 2008; Nopoulos et al., 2010; Johnson et al., 2015). More recently,
brain networks are being rapidly explored because biomarkers such as brain imaging measures may
organize into networks of connected regions (e.g., Alexander-Bloch et al., 2013a). Studies have re-
vealed the importance of structural connectivity, which is the inter-regional anatomical associations
between neural elements (e.g., axons), on disease etiology and progression (Fornito et al., 2016).
One approach to study structural connectivity is to investigate the co-variation patterns of the mor-
phometric characteristics of grey matter regions (e.g., structural co-variation patterns of regional
brain cortical thickness and volumes) from structural magnetic resonance imaging (MRI) data.
Such patterns are considered to be caused by axonal connections (Lerch et al., 2006; Alexander-
Bloch et al., 2013b) and referred to as structural co-variance networks (Alexander-Bloch et al.,
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2013a).
Current methods of constructing structural co-variance networks are at the population level,
by calculating pairwise correlations between cortical thickness or volume of brain regions, each
measured once from each individual in a population (Lerch et al., 2006; Alexander-Bloch et al.,
2013b). However, marked between-subject variability in the structure of a brain region has been
recognized to co-vary with between-subject variability in other brain regions (Alexander-Bloch
et al., 2013a). In addition, structural co-variance networks are strongly influenced by genetic
factors (Schmitt et al., 2008) and change with age (He et al., 2008) and disease status (Seeley et al.,
2009). Therefore, there is a need to develop methods to account for between-subject heterogeneity
when estimating structural co-variance network. A large number of parameters are required to
model between-subject networks; for example, with 20 nodes in a network and 10 covariates, the
number of parameters is on the scale of 4,000. Regularization techniques need to be used to handle
this high-dimensional parameter space.
Besides structural co-variance networks, white matter connectivity from diffusion tensor imaging
(DTI) data and functional connectivity from functional MRI data, measured at the individual level,
are extensively investigated to study human brain networks. Studies have revealed the substantial
overlap between white matter connectivity and structural co-variance network (Alexander-Bloch
et al., 2013a) and the two networks may arise from the same underlying biological network. When
data on another imaging modality (e.g., DTI) are available, they provide an opportunity to es-
timate a more reliable subject-specific target network (e.g., structural co-variance network) by
incorporating individual-level network information from the external modality.
In addition to biomarker networks, cross-sectional personalized symptom networks are con-
structed to investigate the co-occurrence of symptoms in mental disorders (Cramer et al., 2010;
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Borsboom, 2008; Borsboom and Cramer, 2013; Fried and Cramer, 2017). It is of interest to iden-
tify the symptoms with most connections with other symptoms in the network, which offers the
opportunity to develop treatments targeting at these symptoms for each individual. However, cur-
rent methods for estimating symptom networks assume the network is shared across individuals,
which ignores substantial between-subject heterogeneity for patients affected by mental disorders
and neurological disorders (Fried and Cramer, 2017).
In the following of this dissertation, we develop statistical methods to address the above chal-
lenges to construct heterogeneous biomarker networks and impose regularization to handle high-
dimensional parameter space. In Chapter 2, we propose an efficient two-stage procedure to ap-
proximate `0-norm as close as possible. In Chapter 3, we develop a conditional Gaussian graphical
model to identify disease-associated biomarker network features and the technique developed in
Chapter 2 is used to introduce model sparsity and stabilize estimation. In Chapter 4, we use the
methodology developed in Chapter 3 to construct personalized symptom networks. In Chapter
5, we propose a biomarker node-wise graphical model to incorporate information from external
modality to improve the network estimation of target modality. In Chapter 6, we conclude with
the limitations of these works and some extensions.
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Chapter 2
Efficient `0-Norm Feature Selection
Based on Augmented and Penalized
Minimization
2.1 Introduction
Recent advances in high-throughput technologies in genomics and imaging yield unprecedentedly
large numbers of prognostic biomarkers to be examined. The curse of dimensionality poses chal-
lenges for the traditional regression analysis when studying association between high-dimensional
biomarkers and disease outcomes (Friedman, 1997). To cope with the scale of the number of vari-
ables, many regularized methods, which introduce sparsity penalties to the regression models or
likelihood functions, have been developed for simultaneous parameter estimation and variable se-
lection (Tibshirani, 1996, 1997; Zou and Hastie, 2005; Simon et al., 2011; Li and Li, 2010; Sun et al.,
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2014). The most ideal penalty for the variable selection purpose is the `0-norm of the regression
coefficients for all predictors, which is equivalent to the number of non-zero terms among the coef-
ficients, and also referred to as the best subset selection. Unfortunately, due to the non-convexity
and discontinuity of the `0-norm, solving such a regularized optimization is computationally chal-
lenging, known as non-deterministic polynomial-time hard (NP-hard) (Natarajan, 1995). Instead,
other continuous or smooth penalties have been suggested in different contexts (Tibshirani, 1996,
1997; Zou and Hastie, 2005; Simon et al., 2011; Li and Li, 2010; Sun et al., 2014). Particularly,
the convex penalty based on the `1-norm (Tibshirani, 1996, 1997), `2-norm, or their combination
(Zou and Hastie, 2005; Simon et al., 2011) was introduced as a relaxation of `0-norm, providing a
computationally attractive regularization form.
Alternative approaches based on non-convex penalties such as smoothly clipped absolute devi-
ation (SCAD) (Fan and Li, 2001, 2002) and approximate `0-penalty (Liu and Wu, 2007; Li et al.,
2012) apply less shrinkage on large coefficients and hence reduce the estimation bias. Moreover,
non-convex penalties may yield the property of oracle variable selection in the large sample sense.
However, one difficulty of using non-convex penalties is computational instability and sensitivity to
initial values. None of these methods directly use the `0-penalty, and thus likely will still include
some variables with small effects in the final model, especially under the high-dimensional data
framework with large p and small n. For example, Lin et al. (2010) showed that `1-regularized
methods never outperform their `0 counterpart, and may be much worse in some cases. Advance-
ment for `0-norm feature selection is low, where the main methods are greedy algorithms such as
stepwise regression or orthogonal matching pursuit (Mallat and Zhang, 1993). Penalized regression
based on regularizing `0-norm remains much less explored in the literature. The penalty function
proposed in Shen et al. (2012) targets `0-norm but involves heavy computation and non-convex
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optimization.
To address gaps in knowledge, we propose an efficient two-stage method that aims to regularize
`0-norm as close as possible and can be solved by a highly efficient and simple computational
algorithm. Our method shares two features with the recently popular alternating direction method
of multipliers (ADMM) algorithm (Boyd et al., 2011): (1) introducing surrogate parameters to
augment the original model space; and (2) updating original parameters and surrogate parameters
with iteratively alternating optimization. To describe the difference with the ADMM, note that it
solves optimization problems of the form
min
β,θ
f(β) + g(θ), subject to Aβ +Bθ = C,
where all f(β) and g(θ) are convex functions. However, a fundamental difference is that g(θ) is the
`0-norm of θ in our method, so it is non-convex. Using `0-norm, our variable selection retains an
authentic sparsity penalty. Another difference is that the ADMM obtains step sizes for parameter
updates as solutions to the Lagrange equations. However, we can regard our soft-thresholding
followed by hard-thresholding procedure as arising from a truncated `1-penalty function and treat
step sizes as tuning parameters. Thus, we will use cross-validation instead of Lagrange equations
to determine their values, and our tuning parameters are chosen adaptively to the data at hand.
We refer to our method as the augmented penalized minimization (APM-L0). Specifically,
APM-L0 iterates between a commonly used regularized regression step and a hard-thresholding
estimation step, which can avoid the computational challenges encountered in the `0-regularization
problems. To implement APM-L0, we develop a one-step coordinate descent algorithm taking into
account the sparsity structure, which results in both significant reduction in memory usage and
high efficiency in computation. Furthermore, we propose to simultaneously tune the regularization
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parameters in both steps based on cross-validation. The method is flexible enough to handle a
variety of models (e.g., linear model, logistic model, or Cox proportional hazards model (Cox,
1972)) and structure among variables by imposing a Laplacian penalty (Li and Li, 2010; Huang
et al., 2011). We demonstrate better estimation accuracy, much improved model sparsity, and
reduced computational burden over the commonly used `1-type penalties via extensive simulation
studies. We provide real data analyses to demonstrate the practical applicability of APM-L0.
Lastly, a publicly available R-package APML0 is provided and shown via simulations to speed up
computation faster than the commonly used R-package glmnet (Friedman et al., 2010).
The rest of this work is organized as follows. In Section 2.2, we describe the `0-penalized
problems and present the details of APM-L0 approach. We also describe an efficient one-step
coordinate descent algorithm for the implementation. In Section 2.3, we first evaluate the estimation
and selection performance of our method and show large efficiency gain in simulation studies. In
Section 2.4, we apply APM-L0 to a real world example: a recently completed comprehensive
study on Huntington’s disease (HD), PREDICT-HD (Paulsen et al., 2014), where the whole brain
structural magnetic resonance imaging (MRI) measures are used to estimate a network regularized
biomarker signature for the age-at-onset of HD. Lastly, we conclude with a few remarks in Section
2.5.
2.2 Methods and Computational Algorithm
2.2.1 Regression Model with `0-Penalty
Let β denote a vector of coefficients in a regression model and let l(β) denote a log-likelihood
function chosen appropriately depending on the outcome. For example, for continuous outcomes,
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l(β) is based on linear regression model; and for censored outcomes, l(β) is based on the partial
likelihood under the Cox proportional hazards model (Cox, 1972) (details in Section 2.2.5). With a
large number of biomarkers including genomic and imaging features, directly maximizing l(β) may
not be feasible and it is necessary to impose regularization and perform variable selection. The ideal
but computationally infeasible feature selection is the best subset selection, that is, performing a
regularized regression imposing penalty on the `0-norm of coefficients:
min
β
−n−1l(β) + ρ‖β‖0, (2.1)
where ‖β‖0 =
∑p
j=1 I(βj 6= 0) and βj is the jth component of β.
However, due to the non-convexity of the `0-norm, it is difficult to solve (2.1) with the penalty
function p(β) = ρ‖β‖0, computationally known as NP-hard: in order to select the best subset
of non-zero coefficients, we need to evaluate all the possible combinatorial subsets, which grows
exponentially with the number of covariates. Existing approaches based on more continuous penalty
functions (e.g., `1-, `q-norm instead of `0-norm) may often select many non-zero β’s with small
magnitude, which leads to a non-parsimonious model and inferior prediction on independent data
due to overfitting, a common challenge for high-dimensional data analysis with large p and small
n.
Remark. In some applications, components of biomarker variables X exhibit correlation struc-
ture (e.g., correlated gene expressions or brain imaging region of interest (ROI) measures). Such
correlation can be naturally described by a network structure through a Laplacian matrix  L asso-
ciated with the network graph. For example, Li and Li (2010) and Huang et al. (2011) discussed
incorporating such a Laplacian quadratic penalty βT  Lβ into the log-likelihood to perform network-
regularized variable selection. This penalty encourages smoothness of the coefficients of predictors
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that are linked on the network. To accommodate network-informed penalty function, the first term
in (2.1) can be expanded to −n−1l(β) + ρ2βT  Lβ by taking into account such a network structure,
where ρ2 is a tuning parameter for the Laplacian prior and is selected by cross-validation.
2.2.2 APM-L0 for the `0-Penalized Variable Selection
Our proposed computational method to solve the NP-hard problem (2.1), APM-L0, is motivated
by a class of proximal methods performing augmentation and splitting, including the ADMM. In
a nutshell, APM-L0 is a two-stage iterative procedure where the first stage solves a regularized
regression with computationally tractable penalty function, and the second stage performs hard-
thresholding. The procedure is simple and highly computationally efficient. To illustrate the
method, we re-formulate the objective function (2.1) by augmenting the `0-norm of β with a
surrogate parameter θ and bound the difference by a smooth convex function which guarantees
convergence in the proximal of β:
− n−1l(β) + ρ‖θ‖0 subject to
p∑
j=1
φj(|βj − θj |)≤ c, (2.2)
where φj(x) is a convex function satisfying φj(0) = 0 and φj(|x|) ≥ 0 for x 6= 0, and c ≥ 0 is a
tuning parameter. A common choice for φj(| · |) is the `2-norm, where φj(|x|) = x2, j = 1, · · · , p.
Denote by λ a penalty parameter (λ > 0). The Lagrangian form for (2.2) becomes
Lλ(β,θ) = −n−1l(β) + ρ‖θ‖0 + λ
p∑
j=1
φj(|βj − θj |). (2.3)
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To minimize (2.3) for a given λ, APM-L0 iteratively update all parameters using the following
algorithm: at the kth iteration,





φj(|βj − θkj |), (2.4)





φj(|βk+1j − θj |), (2.5)
where the superscript is the iteration counter. The algorithm is iterated until convergence.
Note that the above update equation (2.4) is similar to updating a regularized regression. For
(2.5), it is clear that minimization is performed component-wise. Hence, if βk+1j = 0, then θ
k+1
j = 0;




j = 0 depending on whether φj(|β
k+1
j |)





φj(|βk+1j |) > ρ/λ
)
. (2.6)
It can be seen from (2.6) that the `0-penalty works as hard-thresholding the estimates obtained
from the regularized regression in the first step in (2.4). Many convex penalties proposed in the
literature are good choices of φj(·), including `1-penalty (Tibshirani, 1996, 1997), elastic net (a
combination of `1- and `2-penalty) (Zou and Hastie, 2005; Engler and Li, 2009), group Lasso (Yuan
and Lin, 2006) and sparse group Lasso (Simon et al., 2013).
In summary, the APM-L0 approximates solutions to (2.1) via an ADMM-inspired iterative two-
stage method. The first stage replaces `0 penalty with another penalty function that provides
computationally tractable optimization, and the second stage corresponds to hard-thresholding.
From another view, the APM-L0 performs best subset selection based on the magnitude of β
estimated from a regularized regression. By making use of the order and magnitude of β, one can
greatly reduce the computing time to evaluate `0-norm.
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2.2.3 Efficient Computation in the First Stage
When there is no closed form solution for the score function of a penalized regression (e.g., in a
Cox proportional hazards regression), we can apply a quadratic approximation (Simon et al., 2011)
at some point of the current estimate of β (details in Section 2.5). Previous algorithms such as
Friedman et al. (2010) cyclically updated β̂j , j = 1, · · · , p, until some convergence criterion was
met at the local point β̃. Here, instead of Friedman et al. (2010), we take a one-step coordinate
descent approach to update β̂j only. Our one-step algorithm substantially improves computational








where l(β|β̂−j) is the log-likelihood function with all the components fixed except the jth compo-
nent, βj . Furthermore, we construct an active set A = {j : β̂j 6= 0} at the outset and update those
β̂j for j ∈ A only, which is efficient for handling sparse β by reducing the number of updates. Let
η = (η1, · · · , ηn)T = (βTX1, · · · ,βTXn)T = Xβ. The APM-L0 algorithm is
1. (Initialization) Set β̂ = η̂ = 0 and A = ∅.
2. (Active set) Update A at β̂.
3. (Loop) Iterate until convergence of β̂: cyclically update β̂j by (2.7) for j ∈ A.
4. Converge if no update of A; otherwise, go to Step 3 with the updated A.
When evaluating for a path of λ, we use the previous estimate β̂ and active set A as a warm start
for the next λ and follow Steps 2–4.
Remark. For a network graph-constrained log-likelihood, the Laplacian matrix  L is often sparse.
Hence, in the implementation, we use a sparse matrix to represent  L, which greatly reduces memory
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usage and enhances computational efficiency.
2.2.4 Simultaneous Selection of Tuning Parameters
An intuitive understanding of APM-L0 is to iteratively carry out (a) regularized regression as laid
out in the previous section, and (b) perform hard-thresholding. The tuning parameter λ controls
the degree of regularization for the estimators, and the ratio between ρ and λ determines the
number of non-null coefficients (sparsity of the model).
In some cases, the ADMM algorithm can be slow to converge. The original ADMM iteratively
updates the Lagrangian multiplier λ as, at the kth iteration,






where ak > 0 is a step size. The ak needs to be appropriately chosen to ensure the dual func-
tion, defined as g(λ) = infβ,θ Lλ(β,θ), is increasing. Based on the dual optimal λ
∗ obtained by
maximizing g(λ), we can recover the primal optimal estimates β∗ and θ∗.
Instead of iteratively updating β, θ and λ, we propose to treat λ as a tuning parameter and
search over a set of grid points of λ. At each fixed value of λ, we update β̂ and θ̂ based on the
optimization problems (2.4) and (2.5). To save computational time, we advocate one iteration
update for β and θ, and declare θ̂ as our final estimate. Hence, it is feasible that the algorithm
to solve the `0-penalty runs as fast as other regularized regressions (e.g., `1-penalized regression).
Thus, given λ and ρ, our method is implemented in a two-stage fashion:











φj(|β̂ − θj |).
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The path of λ can be set as in Friedman et al. (2010). In the second stage, we arrange |β̂|
in decreasing order and directly choose the number of non-null coefficients in β̂ by keeping the κ
largest coefficients of |β̂|. We set the path of κ from zero to the total number of non-null coefficients
of β̂. We propose to use cross-validation to simultaneously select both parameters κ and λ. For
example, we suggest to use least squared error for linear regression and partial-likelihood for Cox
model (van Houwelingen et al., 2006) as cross-validation criteria.
2.2.5 Examples of Regression Models and Penalty Functions
We can use any log-concave function/model to replace l(β) in the proposed APM-L0. Let Xi =
(Xi1, · · · , Xip)T denote a vector of covariates and yi be the response variable. For linear regression





For time-to-event outcomes (e.g., age-at-onset of a disease) subject to independent censoring, we
consider Cox model. Let Ti be the time-to-event of interest and Ci be the censoring time. Denote
by T̃i = min(Ti, Ci) the observed event time or censoring time and denote by δi = I(Ti ≤ Ci) the














k : T̃k ≥ T̃i
}
denotes the risk set at time T̃i. Because there is no closed form when
solving (2.7), we use the method proposed by Simon et al. (2011). We approximate l(β) based on
its second-order Taylor series expansion centered at β̃ (estimated β from the previous iteration)
and further approximate the Hessian matrix of l(η) by it’s diagonal matrix to obtain the following
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i : T̃i ≤ T̃j
}
. With little effort, we can extend APM-L0 to other models, such as
general linear models. In the subsequent numeric studies, we focus on linear and Cox models.
To reduce the risk of overfitting and incorporate prior biological information, Laplacian penalty
is often considered (Li and Li, 2010) to regularize estimation.
2.3 Simulation Studies
2.3.1 Simulation Design and Results
We conducted extensive simulations to evaluate the performance of APM-L0. We chose φj(|x|)
to be the `1-type penalty function, which provides a computationally attractive form to reduce
dimensionality. We compared the proposed method with the commonly used `1-type penalized
regressions including Lasso (Tibshirani, 1996, 1997), Enet (Zou and Hastie, 2005; Simon et al.,
2011), Net and its adaptive version, adaptive network penalty (ANet; Li and Li, 2010; Sun et al.,
2014) for both linear regression and Cox model. For simplicity, we refer to these methods as
“`1-type”, to be distinguished from our proposed APM-L0.
To mimic potential correlation between covariates in real world applications, we constructed
X in independent blocks and the nodes within each block were correlated with a correlation of
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0.5. Each block consisted of five nodes and 15 nodes/covariates from three blocks had non-zero
effects on the outcome. We fixed the number of covariates in each node at five but varied the
total number of covariates, denoted by p. We considered two types of outcome in the simulation,
continuous and censored data. For linear regression, we generated Yi =
∑15
j=1 βjXij + εi, where
βj = (−1)j × 2 exp(−(j − 1)/15) and εi ∼ N(0, 1). For Cox model, the underlying hazard function




, where ρ0(t) was specified by a Weibull distribution
with shape parameter 5 and scale parameter 2 and βj = (−1)j×2 exp(−(j−1)/15). The censoring
status was generated from a uniform distribution and randomly assigned to 30% subjects.
In the simulations, we considered sample size n = 200 with various numbers of covariates.
For each simulated dataset, the searching path for λ has a length of 20. Ten-fold cross-validation
was applied to choose the optimal tuning parameters. Simulations were repeated 100 times. To
evaluate estimation performance, we computed the sum of squared errors (SSE) of the estimated
parameters. We also calculated the number of true positive covariates (TP; number of non-null
variables correctly selected in the final model) and the number of false positive covariates (FP;
number of null variables incorrectly selected in the final model) as measures of the variable selection
performance. For the Cox model, we computed the out-sample concordance index (C-index) using
100 random partitions of data into a training set and testing set.
Table 2.1 summarizes these simulation results. It can be seen from Table 2.1 that APM-L0
significantly outperforms the commonly used `1-type methods based on cross validation of the
partial likelihood (L-CVpl) in terms of both estimation accuracy and selection performance for all
cases. The improvement is substantial with smaller SSE, comparable TP and much less FP for
both linear regression and Cox regression. As the number of covariates increases, it becomes more
difficult to pick true positive covariates and remove noise covariates. For the setting with small
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number of covariates where p = 50, both methods are able to select all the true positive covariates
but APM-L0 selects 20 times fewer FP than the `1-type methods. As p increases to 10000, less
TP are selected, yielding larger SSE. When p = 10000, the `1-type methods select slightly more
TP than APM-L0, but still many more FP, and hence a worse SSE. Comparing different choices
of the penalty functions in the first stage φj(·) in APM-L0, we find that ANet performs the best
since it takes into account of the correlation structure among covariates and adjusts the signs of
highly-linked covariates. APM-L0 with Anet penalty gives a higher C-index than CVpl for Cox
model when p = 1, 000 or p = 10, 000. The remaining three penalties have similar performance.
We also performed additional simulations with APM-L0 under a fixed λ and number of non-null
variables, κ. We fixed λ at 0.01, 0.05, and 0.1 and κ at 10, 20 and 30 and used a Lasso penalty as
an example. When comparing APM−L0 with the best scenario of fixing λ and κ, the former yields
a higher C-index, a lower number of false positives when p = 50; and gives a slightly lower C-index
but less number of false positives when p = 1, 000 or p = 10, 000.
2.3.2 Running Time
We compared the running time of our R-package APML0 implementing APM-L0 with glmnet
(Friedman et al., 2010) under the same parameter settings for various sample sizes and numbers
of covariates. As glmnet can only handle Enet and Lasso, the comparison was only performed
for these two penalties. To make the algorithms comparable, we generated the path of tuning
parameter λ from glmnet and used the same path in the first stage of our method. All calculations
were carried out on an Intel Xeon 2.13 GHz processor.
Table 2.2 shows the running time comparison between APML0 and glmnet. Our implementation
was called from R, and most intensive computation codes were written in C++ and integrated with
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R using R-package Rcpp (Eddelbuettel et al., 2011). In Table 2.2, we observe that APML0 and
glmnet have similar running time for linear regression but APML0 runs faster than glmnet for Cox
regression. Similar algorithm was used by both packages for linear regression. For Cox model, a
quadratic approximation is needed at a local point. APML0 takes one-step coordinate descent at the
local point rather than full optimization as done by glmnet. Obtaining high precision of estimates
for the intermediate steps is not necessary. Similar idea was adopted in Mittal et al. (2014).
Additional simulations with different distribution of covariates, correlations among covariates, and
comparison with ADMM are presented in the Appendix A.2.
2.4 Analysis of Real Data
There is increasing evidence that brain imaging markers are important biomarkers for predicting
diagnosis and progression of neurodegenerative disorders (Feigin et al., 2007; Paulsen, 2010; Paulsen
et al., 2014). Current work in the clinical literature mostly perform univariate analyses to assess
association between individual variables and disease outcome. However, theoretical investigation
(Tibshirani, 1996) and various empirical studies (Teipel et al., 2015) suggest that simultaneous ap-
proaches based on penalized regressions may avoid overfitting and provide more power than massive
univariate approaches or greedy-search based stepwise regressions. Here, we take a whole-brain ap-
proach to evaluate all regional imaging measures simultaneously in predicting age-at-onset (AAO)
of Huntington’s disease (HD). Regional brain atrophy measures obtained from structural magnetic
resonance imaging (MRI) have been suggested as one of the most robust imaging biomarkers for
HD (Ross et al., 2014). We analyzed the data from the newly completed PREDICT-HD study
(Paulsen et al., 2014) to predict AAO of HD using whole brain subcortical volumetric measures
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obtained from structural MRI. The regional summary volumetric measures were created by a fully
automated procedure and pre-processed using Freesurfer 5.2 (http://surfer.nmr.mgh.harvard.edu).
Details on the imaging marker preprocessing have been reported previously (Paulsen et al., 2014).
Our analysis consists of 840 subjects who were at genetic risk of HD (CAG repeats length ≥36 at
the huntingtin gene (MacDonald et al., 1993)). The median follow up time was 3 years and 128
subjects developed HD during the study. In our analysis, there were 8 clinical variables (gender,
education, baseline total motor score from the UHDRS, and cognitive and functioning measures)
and 28 subcortical MRI imaging ROI biomarkers measured at the baseline visit. To account for
correlation among imaging measures, elastic net (Enet) penalty and Laplacian penalty was used
for the function φj(·) in the APM-L0. We used control subjects (no HD mutation, CAG repeats
length < 36) in PREDICT-HD to estimate the correlation matrix used in the Laplacian penalty.
All variables were standardized before fitting the model.
We compare APM-L0 with the usual penalized regression implemented in glmnet using cross-
validation to select tuning parameter (referred to as L-CVpl). To obtain an out-of-sample measure
of performance, we randomly partitioned the data into a training set and testing set, where we
used the training set to fit the data and testing set to estimate the performance. We used ten-
fold cross-validation to select tuning parameter on the training set. Table 2.3 shows that given a
penalty function, the proposed APM-L0 procedure selected less number of biomarkers than L-CVpl
(on average 8.17 variables less under ANet penalty and 4.14 variables less under Lasso penalty),
without sacrificing the prediction performance (comparable cross-validated C-index (Harrell et al.,
1982), brier score (Brier, 1950), and partial likelihood). Moreover, APM-L0 under sign-adjusted
ANet penalty has higher C-index, lower Brier score and higher partial likelihood than under Lasso
penalty. We further show the estimated standardized regression coefficients (effect sizes) in Figure
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2.1 for all four procedures. Comparing APM-L0 with L-CVpl, we see that the former removed
several biomarkers with small effects (e.g., Left Lateral Ventricle) which were clearly noise variables
from a biological point of view, while strengthening effects from ROIs such as Putamen, Thalamus,
and Palladium. Comparing Lasso penalty with sign-adjusted ANet, we see that the former does
not select ROIs shown to be highly predictive in prior literature (Paulsen et al., 2014) such as left
or right side of Putamen. In addition, ANet can select the linked biomarkers with opposite effects,
such as left and right sides of hippocampus, which indicates the necessity of controlling for the
direction of association of biomarkers.
Some of the variables selected by APM-L0 are consistent with previously identified in the
literature (Paulsen et al., 2014) from the PREDICT-HD study. However, previous literature did
not take a multivariate approach so that the relative ranking of biomarkers’ ability to predict HD
onset in a multivariate model is unknown. Based on their effect sizes as shown in Figure 2.1, the top
ranking clinical variables include total motor score, Stroop inference score, Stroop word score, and
the top ranking imaging biomarkers include Thalamus, Putamen, Caudate, Hippocampus ROIs,
and cerebellum white matter and cerebellum cortex. The symbol digital modality (SDMT) drops
out of the model when Stroop scores are selected into the model. Noisy markers such as left and
right lateral ventricle are not selected into the model.
Due to better interpretability and prediction performance, we present further results of APM-
L0 under ANet penalty. We estimated the structural covariation network (He et al., 2008) from
control subjects (no HD mutation) in PREDICT-HD. The estimated network was then used to
construct Laplacian penalty in the estimation of the effects of ROIs. Thus, the highly correlated
ROIs were encouraged to express similar effects as in Li and Li (2010). We show in Figure 2.2 the
imaging network signature and their effect sizes. For graphical presentation purpose, Figure 2.2
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Figure 2.1: Forest plot of standardized effect sizes for biomarkers selected by CVpl Lasso, APM-L0
Lasso, CVpl Anet, APM-L0 Anet.
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only displays estimated non-null ROIs and their strongly associated edges. Each edge represents
two ROIs with the absolute value of correlation greater than a threshold (0.8) in the covariation
network and the size and color of nodes represents the effect and direction of an ROI on the
age at onset of HD, respectively. More ROIs were chosen by L-CVpl compared with APM-L0.
The networks identified by L-CVpl with small effects were removed by APM-L0 (i.e., Choroid
Left-Choroid Right). Furthermore, the effects of important ROIs were strengthened by APM-L0,
indicated by larger radius of nodes in Figure 2.2. These results show that APM-L0 has the desirable

















































Figure 2.2: Comparison of network identified by ANet based on L-CVpl (left (a)) and proposed
APM-L0 (right (b)), with radius indicating effect sizes and color indicating signs of effects (blue:
positive; red: negative).
To assess the ability of biomarkers in discriminating individuals who will have an onset of HD
by certain age t from those who will not, we split subjects into high-risk and low-risk group based
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on their biomarker risk scores (i.e., βTX). Receiver operating characteristic curve (ROC) analysis
is applied to select the optimal cutoff values of risk scores for predicting risk by age t =40, 50,
60, or 70, respectively. The cutoff values are determined by minimizing the difference between
the points on the ROC curve and the point (0,1) on the upper left hand corner of ROC space
(Greiner et al., 2000). Subjects are divided into high risk group and low risk group based on the
optimal cutoff values. Figure 2.3 shows the cumulative risk of developing HD in high risk group
and low risk group estimated from Kaplan-Meier curves. It indicates a large difference between
the high-risk group and low risk group. We computed time-dependent AUCs using the method in
Chiang and Hung (2010) that can account for censoring implemented in the R package “timeROC”.
The AUCs of risk scores obtained from APM-L0 is high: at age 40, 50, 60 or 70, the AUCs are
0.84, 0.87, 0.91 and 0.89, respectively. To visualize the ability of biomarkers with largest effect
sizes in discriminating high- and low-risk individuals, we present 2-biomarker split plots in Figure
2.4. The decision boundary in each figure is obtained by fixing other biomarkers at the sample
averages. They show some discriminant power for separating high risk group and low risk group
by Pallidum-Left and Thalamus-Left, or Pallidum-Left and Thalamus-Right, especially at t = 50
or t = 60. For lower or higher age, the discriminant power of the two top ranking biomarkers is
limited and borrowing information from other biomarkers is necessary to achieve higher predictive
performance.
2.5 Discussion
In this work, we propose a two-stage procedure under the ADMM framework to approximate
solutions to the `0-penalty variable selection. We develop an efficient one-step coordinate descent
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Figure 2.3: Estimated cumulative risk of HD diagnosis using APM-L0 Anet. From left to right,
results are obtained at age 40, 50 ,60, and 70. Blue: high risk group. Red: low risk group.
algorithm for implementation. Our APM-L0 approach improves both estimation and selection
performance substantially over the commonly used regularized methods. The one-step coordinate
descent algorithm runs faster than existing algorithms which fully optimizes the estimates at each
step. Taking into account the sparsity structure allows for further improvement on the computation
efficiency.
Here we focus on linear regression and Cox model, and demonstrate the procedure mainly using
`1-type penalties in the first stage for φj . However, the proposed approach can easily be extended to
other types of outcomes and penalty forms. One would replace the log-likelihood function with any
other log-concave function to obtain a similar procedure. It would be interesting to explore other
shrinkage methods, such as SCAD (Fan and Li, 2002) or MCP (Zhang, 2010). We expect similar
results such that APM-L0 would achieve better sparsity and accuracy than alternative methods.
Furthermore, our algorithm can be improved and easily adjusted for massive sample-size data by
accounting for the sparsity in the covariates matrix. Lastly, in this work baseline biomarkers are
used to predict disease onset. Another extension worth considering is the inclusion of longitudinal
measures of biomarkers over time in a time-dependent model to update predictive function for
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Figure 2.4: 2-biomarker split plots using APM-L0 Anet. The top row shows Pallidum-Left versus
Thalamus-Left. The bottom row shows Pallidum-Left versus Thalamus-Right. From left to right,
the cutoff values are optimized for distinguishing onset by age 40, 50, 60, and 70. Blue: high risk
group. Red: low risk group. Black line: separation boundary. Large filled circles: subjects with a
diagnosis by certain age. Dots: subjects without a diagnosis by certain age.
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disease onset.
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Table 2.1: Comparison of estimation and selection performance for linear regression and Cox model
based on the proposed APM-L0 and existing `1-type methods for penalties ANet, Net, Enet and
Lasso with various numbers of covariates.
SSE1 TP2 FP3
CVpl APM-L0 CVpl APM-L0 CVpl APM-L0
Linear regression
n = 200, p = 50
ANet 0.26 0.18 15.0 15.0 25.4 1.5
Net 0.38 0.25 15.0 15.0 19.4 1.4
Enet 0.37 0.25 15.0 15.0 18.8 1.4
Lasso 0.37 0.25 15.0 15.0 18.9 1.4
n = 200, p = 1000
ANet 1.86 1.39 14.8 14.7 213.4 1.1
Net 2.49 1.90 15.0 14.7 125.3 1.3
Enet 2.41 1.86 15.0 14.6 125.5 0.9
Lasso 2.13 1.51 15.0 14.9 116.7 1.3
n = 200, p = 10000
ANet 14.57 13.60 11.6 10.3 438.2 4.2
Net 16.85 15.92 9.6 7.5 95.5 6.2
Enet 16.29 15.80 9.8 7.5 102.3 7.3
Lasso 15.67 15.28 9.9 7.7 99.8 7.3
SSE1 TP2 FP3 C-index4
CVpl APM-L0 CVpl APM-L0 CVpl APM-L0 CVpl APM-L0
Cox model
n = 200, p = 50
ANet 1.36 0.55 15.0 15.0 27.5 1.6 0.912 0.915
Net 2.35 0.89 15.0 15.0 19.3 0.5 0.901 0.906
Enet 2.35 0.89 15.0 15.0 19.3 0.5 0.901 0.907
Lasso 2.29 0.88 15.0 15.0 18.6 0.6 0.902 0.907
n = 200, p = 1000
ANet 13.28 6.90 14.0 13.5 158.9 0.8 0.800 0.844
Net 19.59 14.39 11.5 10.3 39.2 2.0 0.704 0.710
Enet 19.28 13.89 11.6 10.5 38.8 1.7 0.703 0.712
Lasso 19.01 13.11 11.7 10.8 37.5 1.5 0.700 0.709
n = 200, p = 10000
ANet 23.48 17.15 8.8 9.3 124.8 1.8 0.669 0.725
Net 25.74 23.74 6.0 5.6 25.8 2.9 0.655 0.663
Enet 25.72 24.12 5.5 4.9 19.9 3.7 0.646 0.644
Lasso 25.68 24.25 5.4 4.4 17.3 2.9 0.641 0.641
1SSE: Sum of squared error; 2TP: Number of true positive covariates; 3FP: Number of false positive
covariates ; 4C-index: Concordance index.
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Table 2.2: Running time in seconds for R-packages APML0 and glmnet for various sample sizes
and number of covariates.
Linear regression Cox model
Enet Lasso Enet Lasso
APML0 glmnet APML0 glmnet APML0 glmnet APML0 glmnet
n = 200, p = 1000 0.11 0.27 0.06 0.09 1.06 4.34 1.35 7.69
n = 200, p = 10000 0.70 0.85 0.75 0.67 5.25 17.19 2.51 26.54
n = 5000, p = 1000 2.79 3.00 2.82 2.95 44.55 60.25 41.16 53.39
n = 5000, p = 10000 10.95 10.35 10.78 10.33 226.70 370.35 147.40 788.59
Table 2.3: Average number of variables selected, C-index, Integrated Brier Score and Partial Like-
lihood by the proposed APM-L0, L-CVpl with ANet, Net, Enet and Lasso penalty (100 repetitions
of 10-fold cross validation).
Number of variables C-index Integrated Brier Score Partial Likelihood
ANet Lasso ANet Lasso ANet Lasso ANet Lasso
L-CVpl 27.32 14.44 0.800 0.791 0.067 0.068 -5.661 -5.688
APM-L0 19.15 10.30 0.792 0.785 0.068 0.069 -5.682 -5.709
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Chapter 3
Identifying Disease-Associated
Biomarker Network Features Through
Conditional Graphical Model
3.1 Introduction
The morphological features of some brain regions (e.g., thickness and volume of grey matter) co-
vary with other regions (Alexander-Bloch et al., 2013a). Such co-variation patterns are referred
to as structural co-variance networks which may characterize coordinated patterns in morphology
between anatomically connected regions of interest (ROIs) (He et al., 2008). Recent studies have
suggested presence of substantial heterogeneity of co-variance network connections between individ-
uals and subgroups of individuals. For example, the strengths of brain cortical region connections
were observed to vary with age (Chen et al., 2011) and the structural co-variance patterns were
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altered across the lifespan (Alexander-Bloch et al., 2013a). In our motivation study of Huntington’s
disease (HD; Paulsen et al., 2014), the networks of high-risk group and low-risk group are different
in terms of connected edges and their edge strengths (about 70% shared edges; details in Section
4).
The patterns of heterogeneous structural covariation connections among regions have been
shown to predict disease phenotypes. Alexander-Bloch et al. (2013a) suggests that behavioral and
cognitive abilities are associated with the between-region co-variation patterns in addition to the
variability within the regions. Siegel et al. (2016) found that functional connectivity better predicts
visual memory and verbal memory than lesion locations in a stroke cohort study. Bohlken et al.
(2016) showed that brain white matter connectivity contributes to the genetic liability of schizophre-
nia. These findings suggest network connectivities between brain regions can be predictive of disease
clinical outcomes beyond the within-region imaging measures. Thus, it is desirable to evaluate the
relative clinical utility of network connections in context of the within-region biomarkers and other
existing disease risk factors.
There is no existing method readily available to estimate heterogeneous grey matter structural
covariation networks and their effects on a disease outcome. First, unlike the white matter con-
nectivity network which can be obtained by probabilistic tractography in each individual, grey
matter co-variation network between regional volumetric measures is not directly available on each
individual. By leveraging between-subject variability and modeling dependence between network
strength and individual covariates (e.g., age, genetic variants), subject- or subgroup-specific grey
matter network connections may be obtained. Second, there is a lack of methods to estimate hetero-
geneous networks in a multi-dimensional setting. When the network is assumed to be homogenous
across individuals, Gaussian graphical models (Friedman et al., 2008; Han et al., 2016) have been
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extensively used to estimate a high-dimensional network defined by the inverse covariance matrix
(i.e., precision matrix). Fused graphical lasso (FGL; Danaher et al., 2014) was proposed to jointly
estimate graphical models for multiple distinct classes but assume the classes are known. To address
between-subject variability, Yin and Li (2011), Cai et al. (2012), and Chen et al. (2016) proposed
to adjust the mean of variables in the network for covariates but still assume a constant precision
matrix. Cheng et al. (2014) incorporates covariates directly into an Ising model of the network
but under some modeling assumptions. Third, to the best of our knowledge, no existing method
exploits heterogeneous network strength to construct subject- or subgroup-specific networks and
use them as potential intermediate phenotypes on disease outcomes.
A straightforward method to estimate subject-dependent network is to stratify the samples
into subgroups, estimate a network by Gaussian graphical model (Friedman et al., 2008) for each
group separately, and associate the edge effects of each group with disease outcomes. However, it is
unknown how the subgroups should be formed. Furthermore, such a method is inefficient when the
number of subgroups is large and subjects in each group is small. In our motivating study, 97 edges
were identified in the network of high-risk subgroup while 88 edges were identified in the low-risk
network (Figure 3.1). There were 69 common edges in the two networks. The Hamming distance,
defined as the sum of the absolute edge-wise differences between two adjacency matrices, between
two networks is 9.1, and the weighted correlation is 0.87. Thus, although two networks do not have
identical structure and connection weights vary, they share more than 70% edges and manifest
correlated edge effects. These results suggest a more efficient approach to model the network edge
strengths as a function of covariates to provide subject-dependent networks.
We propose a two-stage method to estimate biomarker networks that account for heterogeneity
among subjects and evaluate network’s association with disease clinical outcome. In the first
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Figure 3.1: High-risk network (left panel) and low-risk network (right panel) by graphical lasso.
Solid edge: common edge between high-risk and low-risk networks; dashed edge: group-specific
edge.
stage, we propose a conditional Gaussian graphical model to capture subject-dependent network
connections, in which both the mean and precision matrix of the graphical model depend on
individual covariates. To handle multi-dimensional parameter space, regularization is imposed
to introduce model sparsity and stabilize estimation.
The first-stage model will provide subject-specific network measures (edge connection strengths)
between biomarkers. The identified network can be dense, but not all of the network connections
are associated with clinical impairment which reduces their clinical utility. Thus, in the second
stage, we use a penalized regression that includes existing disease risk factors (covariates), within-
region biomarkers, and between-region connections to simultaneously examine their clinical utility.
The goal in the second stage is to further evaluate relative predictive power of network measures
on clinical impairment compared to using within-region biomarkers and covariates alone.
Our method makes several contributions. The first stage model captures heterogeneity of net-
CHAPTER 3. IDENTIFYING DISEASE-ASSOCIATED BIOMARKER NETWORK
FEATURES THROUGH CONDITIONAL GRAPHICAL MODEL 32
work connection strength without assuming the connections are directly measured on each individ-
ual. Such effects are captured by covariates and represent some smooth changes over the covariate
space and subgroups of subjects. The second stage model simultaneously considers a large number
of biomarkers and connections as intermediate measures without first taking any transformation
or dimension reduction. Third, since it is unknown which connections between biomarkers are
associated with clinical impairment (e.g., a lower connectivity between certain brain regions may
associate with poor cognition), our method identifies important network features with additive
clinical utility in the context of existing risk factors.
3.2 Methodology
Let Xi denote a q-dimensional vector of disease risk factor (e.g., covariates including genetic vari-
ants, baseline clinical measures) of the ith subject. Let M i denote a vector of p-dimensional
biomarkers. Let Yi denote a clinical outcome of interest. In our application in Section 3.4, Xi
includes DNA structural variation at a causal gene and baseline clinical measures, M i includes
cortical and subcortical brain atrophy volumetric measures at ROIs available from structural mag-
netic resonance imaging (MRI), and Yi is the rate of change of motor symptoms. The structural
co-variation network is defined as the precision matrix of M i. An overview of schematic diagram of
our method is shown in Figure 3.2. Specifically, the first stage model estimates subject-dependent
networks of M i given Xi and connections between components of M i from a conditional Gaussian
graphical model. The second stage model identifies which network connections between nodes have
incremental effects on clinical outcomes in addition to M i’s and Xi. This model also estimates
the effect of Xi on Yi through connections between M i.
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Figure 3.2: Schematics of the proposed two-stage method.
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3.2.1 First Stage Conditional Network Model
A conditional Gaussian graphical model for the distribution of M i given Xi, where both the mean
and precision matrix of M i depend on Xi, can be expressed as
P (M i|Xi) ∝ exp
(






where the jth element of κi is κij = ζ
T
j Xi, and the (j, k)th element of Ωi is
Ωi(j, k) =

1/σ2εj j = k
−ωjk(Xi) j > k
Ωi(k, j) j < k.
In this model, the subject-dependent network connection between nodes Mj and Mk is modeled by




In the conditional Gaussian graphical model (3.2), we assume that the heterogeneity in network
connection across subjects is explained by subject-specific characteristics captured in a vector of
covariatesXi. When κ(Xi) and Ω(Xi) do not vary overXi, our model reduces to regular Gaussian
graphical models (Friedman et al., 2008).
It is computationally intensive to directly estimate the parameters from the likelihood of the
joint distribution in (3.1) due to the presence of a large number of parameters in the covariance
structure. Note that the number of parameters in the covariance matrix is p(p − 1)/2 ∗ q. With
M i and Xi even at a moderate scale, the optimization will be over a high-dimensional parameter
space: with p = 20 biomarkers and q = 10 covariates, the number of parameters is 1, 900. To
compute the estimates efficiently, instead of maximizing the joint likelihood function P (M i|Xi)
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in equation (3.1), we optimize a pseudo-likelihood formed by the products of all node-wise condi-
tional likelihoods P (Mij |M i,\j ,Xi), where M i,\j denotes a vector of M i without the jth element.
Replacing the joint likelihood by pseudo-likelihood reduces the computation to be node-wise and
provides consistent parameter estimates at the cost of statistical efficiency, but makes computation
feasible in the presence of a large number of nodes and covariates. The conditional distribution of
Mij given M i,\j and Xi is a normal distribution with a mean of












P (Mij |M i,\j ,Xi),











Denote the log-pseudo likelihood function by ln(ζ,α,σ
2) = logLn(ζ,α,σ
2). We impose reg-
ularization to stabilize estimation and perform variable selection. Our aim is to minimize the





where p(ζ,α) is a properly chosen penalty function. The most desirable penalty for variable
selection is to constrain the number of variables selected (e.g., l0-penalty), which is equivalent to











s=1 I(ζjs 6= 0) and ‖αjk‖0 =
∑q
s=1 I(αjks 6= 0). However, the optimization
involving this penalty function is non-deterministic polynomial-time hard (NP-hard) due to the
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non-convexity and discontinuity of the l0-norm. A computationally efficient two-step iterative
procedure referred to as APM-L0 was proposed to approximate the l0-penalization as closely as
possible (Li et al., 2018). APM-L0 uses surrogate parameters to augment the l0-norm of (ζ,α)
and guarantees that the surrogate parameters are close enough to (ζ,α). It iteratively solves a
penalized regression problem followed by a hard thresholding. In the first step of APM-L0, we use
a lasso penalty and employ an accelerated generalized gradient algorithm with backtracking for
computation (Simon et al., 2013).
In the second step of APM-L0, hard-thresholding is performed to remove parameters with
small magnitudes (Li et al., 2018). We iteratively update between ζj ,αjk and σ
2
εj until conver-
gence is reached. The tuning parameters are selected using cross-validation to determine a final
subject-dependent network model. The detailed update functions in the algorithm are presented
in Appendix B.1.
3.2.2 Second-Stage Clinical Outcome Model
In the first stage model, our main interest is to estimate the biomarkers network effects (i.e.,
ωjk(Xi)), as well as identifying important edges in the network. Thus, the first stage method
is an unsupervised approach to investigate basic brain organization through estimating subjects’
network connections. In the second stage, we evaluate the clinical utility of the network connections
identified in the first stage. We associate covariates, biomarkers, and the network connections with
clinical impairment.
Under the conditional network model in (3.2), the heterogeneity in network connection across
subjects is explained by the covariates. Mutual information, which quantifies the amount of in-
formation shared by two variables, is used as a measure of network strength in many applications
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(e.g., Song et al., 2012). Under the jointly Gaussian assumption, the mutual information between
two biomarkers given the remaining biomarkers is a transformation of the partial correlation, be-
cause the conditional joint distribution of the two biomarkers is a bivariate normal distribution.
The transformation may alleviate the potential collinearity challenge between network connections
when included in the outcome model. In addition, partial correlation yields an interpretation as
conditional dependence and provides measures for determining modular membership in neuroimag-
ing studies (Section 3.4.1).
The second-stage model for disease outcome is:










, and ρi,sr = − Ωi(s,r)√
Ωi(s,s)Ωi(r,r)
= σεsσεrωsr(Xi) is the partial correlation between Mi,s and Mi,r given M i,\{s,r}. The mutual in-
formation represents the strength of the connection between biomarkers given Xi. If ρi,sr = 0,
then Wi,sr = 0, which implies that no connection is present between Mi,s and Mi,r. If ρi,sr is large,
then Wi,sr is large which suggests a strong connection between Mi,s and Mi,r.
In model (3.3) ηs, ηr and γsr are the effects of Xi on Yi through network nodes and their
connections, and β are the effects of Xi directly on Yi not through nodes and connections. Our
interest is to evaluate the incremental effect of γsr relative to ηs and ηr. In our application, γsr are
the effects of causal gene on the clinical outcome through grey matter connection between a pair
of ROIs (Mi,r,Mi,s).
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are estimated based on the first-stage model, and the penalty
function q(β,η,γ) = λ2(‖β‖0+‖η‖0+‖γ‖0), with ‖β‖0 =
∑q
s=1 I(βs 6= 0), ‖η‖0 =
∑p





r=1 I(γsr 6= 0). We again use APM-L0 with adaptive lasso penalty (the
initial estimators are obtained from a ridge regression) on β, η, γ to obtain parameter estimates.
In practice, stability selection (Meinshausen and Bühlmann, 2010) can be further used to select
informative network connections and important predictors of clinical outcomes. Stability selection
combines subsampling and bootstrap with variable selection to provide improved performance (e.g.,
reduced false discovery rate).
3.3 Simulation Studies
We conducted extensive simulations to evaluate our method. We varied the number of covariates
q, the number of biomarker nodes p, and the sample size n. Five settings were considered. The
first four settings include n = 500 and 1, 000 with p = q = 5, 10, 20; and p > q with (p, q) = (5, 3),
(p, q) = (10, 5), (p, q) = (20, 10). In Setting 5, we increased the number of biomarkers and considered
n = p = 100 and q = 5. In Settings 1 and 2, we simulated covariates Xi independently from a
standard normal distribution, where Setting 1 had homogeneous variance parameters σ2εj = 0.2
and Setting 2 had heterogeneous variance parameters (σ2εj = 0.2 or 0.15). Four of αjk’s are
non-zeros with magnitudes ranging from -1.5 to 1.5 and the remaining αjk’s are all zeros. For
example, α12 = (−0.5,−1,−1.5, 0, 0)T , α23 = (−1,−0.5,−1.5, 0, 0)T , α34 = (1.5,−0.5,−1, 0, 0)T ,
α45 = (−0.5,−1.5, 1, 0, 0)T when p = q = 5 in Setting 1. Setting 3 included additional binary
covariates and Setting 4 additional examined scenarios with p > q. For all the settings, we generated
clinical outcomes in the second stage model from Yi = Xi1+2Xi2+Mi1+3Mi2+Wi,s1r1+2Wi,s5r5+εi,
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where Xi, M i, and W i were standardized and εi ∼ N(0, 1). Here Wi,s1r1 is the mutual information
between Mi1 and Mi2 for p = 5, 10, 20, and Wi,s5r5 is the mutual information between Mi2 and Mi3
for p = 5, and Mi1 and Mi6 for p = 10, 20. The details of the simulation settings are presented in
Appendix B.2.
For each simulated data set, the length of the grid search vector of the tuning parameter λ1 and
λ2 is 10 and 100, respectively. Ten-fold cross-validation was applied to choose the optimal tuning
parameters. Simulations were repeated 100 times for each setting. To only retain the informative
connectivities in predicting the disease outcome, we excluded near constant mutual information
measures (variability<0.005) from the second stage model.
Appendix Figure B1 (Settings 1-4) and Appendix Figure B2 (Setting 5) visualize the number
of times (at least once among 100 simulations) that an edge is identified in the network structure
of M i in the first stage analysis. An edge between Mij and Mik is defined as exist if ‖αjk‖2 6= 0.
Our method correctly identifies all true positive edges (TP; number of non-null edges correctly
selected in the model) in all settings (black lines; line thickness proportional to the number of times
identified; true edges are the black lines.). When p and q increase, some false positive edges (FP;
number of null edges incorrectly selected in the model) are selected with small frequencies (about
2% or 3% times across simulations). In more complicated settings (Setting 2 and 3), more FP
edges are selected especially when p = q = 20. The performance is improved when the sample size
increases to 1, 000. The performance of p > q (Setting 4) is similar to that of Setting 1. More FP
edges are selected when p = 20 and n = 500 in Setting 4 due to the presence of a large number
of parameters (up to 1, 900). However, when the sample size increases to 1, 000, most FP edges
are eliminated. When n = p = 100 (Setting 5, Appendix Figure B2), our method still correctly
identifies all TPs with high frequency and selects some FPs with small frequency.
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Table 3.1, 3.2, Appendix Table B1, B2 and B3 summarize the numeric simulation results. In
Setting 1 (Table 3.1), it can be seen that our method yields a small sum of squared error (SSE),
selects most of TP variables with few FP variables and does not select most of true negative (TN;
number of null edges correctly not selected in the model) variables with very few false negative (FN;
number of non-null edges incorrectly not selected in the model) variables. Matthews correlation
coefficient (MCC) is used as a measure that balances sensitivity and specificity even if the non-
null edge class and the null edge class are of very different size. In the first stage, all of the TP
parameters in (αjk)j>k are selected while small number of FP parameters are selected, and almost
all of TN parameters are not selected. MCC of (αjk)j>k is larger than 0.9. When p = q = 20 and
n = 1, 000, our method identifies all the TPs and only falsely selects 3 parameters, while almost
all of TNs are rejected. MCC is around 0.9. In the second stage, our method identifies all the TP
variables in W i, Xi and M i, along with a small number of FP variables and rejects most of TN
variables. MCC of the connection effects is larger than 0.9. For example, when p = q = 20, the
average number of FP variables in connections is 0.33 when n = 500, and the average number of
FP variables reduces to 0.24 when n = 1, 000. SSE of γ, β, and η are small and they increase
slightly when p and q increase.
Setting 2 is more difficult because σ2εj varies by node. The performance of Setting 2 (Table 3.2)
remains to be satisfactory with slightly more FPs and lower MCC. When p = q = 20, the average
number of FP parameters in (αjk)j>k is 11.03 when n = 500 and it decreases to 3.91 when the
sample size increases to 1, 000. Our method retains all TP variables in the second stage and the
average number of FP variables in connections is still small. MCC of the connection effects is
still beyond 0.8. Larger SSE, fewer TPs, and more FPs appear in Setting 3 (Appendix Table
B1). Our method can still identify almost all TPs and the SSE of γ is decreased by 78% when
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n = 1, 000 compared to that when n = 500. MCC remains large. When p = q = 20 with sample
size n = 1, 000, MCC of γ can reach around 0.85 and MCC of the connection effects is around 0.8.
The results suggest that our method performs better when the subject-specific effects are stronger.
For large p, increasing sample size would improve the estimation and selection performance. In
Setting 4 where p > q, Appendix Table B2 shows a similar performance to that of p = q in terms
of estimation and selection accuracy.
When n = p = 100 (Setting 5, Appendix Table B3), larger SSE and more FPs appear due to
a large number of parameters and a small sample size. Our method can still identify almost all
TPs in (αjk)j>k while most of TNs are not selected, and MCC of (αjk)j>k is about 0.75. We also
identify almost all the TP variables in W i, Xi and M i, and MCC of the connection effects retains
about 0.85 when the sample size is small.
3.4 Applications to the Grey Matter Network of HD
HD is caused by an expansion of CAG triplet repeats in the huntingtin gene (MacDonald et al.,
1993). Existing studies (Rosas et al., 2008; Johnson et al., 2015) have shown that regional brain
grey matter and white matter atrophy were associated with progression of HD as measured by
the rate of change in patient’s motor symptoms. In addition, McColgan et al. (2015) found that
the degree (number of brain connections) of brain regions in white matter connectivity network
(structural network) was highly correlated with motor and cognitive deficits. These existing work
considered brain subcortical volumes and cortical connectivity measures separately. Instead, here
we consider both types of measures on a subject.
We analyzed data collected from the recently completed PREDICT-HD (Paulsen et al., 2014),
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Table 3.1: Estimation and Selection Performance of Simulations in Setting 1.
n = 500 n = 1000
SSE1 TP2 FP3 TN4 FN5 MCC6 SSE1 TP2 FP3 TN4 FN5 MCC6
p = 5, q = 5
1st stage ζ 0.409 8.97 1.44 14.56 0.03 0.883 0.167 9.00 0.94 15.06 0.00 0.923
α 0.183 11.99 1.75 36.25 0.01 0.912 0.066 12.00 1.35 36.65 0.00 0.931
2nd stage γ 0.050 2.00 0.39 7.61 0.00 0.892 0.020 2.00 0.26 7.74 0.00 0.925
β 0.006 2.00 0.22 2.78 0.00 0.914 0.003 2.00 0.32 2.68 0.00 0.878
η 0.021 2.00 0.36 2.64 0.00 0.864 0.007 2.00 0.25 2.75 0.00 0.903
p = 10, q = 10
1st stage ζ 1.106 8.89 3.10 87.90 0.11 0.840 0.455 9.00 2.03 88.97 0.00 0.893
α 0.604 12.00 3.00 435.00 0.00 0.891 0.234 12.00 2.03 435.97 0.00 0.923
2nd stage γ 0.067 2.00 0.43 42.57 0.00 0.903 0.023 2.00 0.36 42.64 0.00 0.917
β 0.012 2.00 1.06 6.94 0.00 0.753 0.004 2.00 0.74 7.26 0.00 0.814
η 0.029 2.00 1.16 6.84 0.00 0.736 0.011 2.00 0.95 7.05 0.00 0.773
p = 20, q = 20
1st stage ζ 2.369 8.43 2.84 388.16 0.57 0.833 0.969 8.98 3.53 387.47 0.02 0.842
α 1.376 12.00 3.91 3784.09 0.00 0.868 0.622 12.00 3.08 3784.92 0.00 0.892
2nd stage γ 0.068 2.00 0.33 187.67 0.00 0.926 0.030 2.00 0.24 187.76 0.00 0.944
β 0.012 2.00 1.85 16.15 0.00 0.683 0.007 2.00 2.04 15.96 0.00 0.663
η 0.031 2.00 1.98 16.02 0.00 0.669 0.013 2.00 2.05 15.95 0.00 0.662
1SSE: Average sum of squared error across 100 simulations; 2TP: Average number of true positive
parameters across 100 simulations; 3FP: Average number of false positive parameters across 100
simulations; 4 TN: Average number of true negative parameters across 100 simulations; 5 FN: Average
number of false negative parameters across 100 simulations; 6 MCC: Matthews correlation coefficient
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Table 3.2: Estimation and Selection Performance of Simulations in Setting 2.
n = 500 n = 1000
SSE1 TP2 FP3 TN4 FN5 MCC6 SSE1 TP2 FP3 TN4 FN5 MCC6
p = 5, q = 5
1st stage ζ 0.425 8.98 1.33 14.67 0.02 0.892 0.176 9.00 1.09 14.91 0.00 0.912
α 0.247 11.95 2.00 36.00 0.05 0.898 0.090 12.00 2.54 35.46 0.00 0.878
2nd stage γ 0.020 2.00 0.51 7.49 0.00 0.864 0.006 2.00 0.52 7.48 0.00 0.861
β 0.007 2.00 0.39 2.61 0.00 0.853 0.003 2.00 0.42 2.58 0.00 0.843
η 0.041 2.00 0.50 2.50 0.00 0.816 0.016 2.00 0.42 2.58 0.00 0.843
p = 10, q = 10
1st stage ζ 1.070 8.80 2.71 88.29 0.20 0.850 0.342 8.99 2.15 88.85 0.01 0.887
α 0.691 11.99 2.50 435.5 0.01 0.907 0.243 12.00 1.89 436.11 0.00 0.927
2nd stage γ 0.051 2.00 0.86 42.14 0.00 0.828 0.019 2.00 0.82 42.18 0.00 0.834
β 0.013 2.00 1.05 6.95 0.00 0.755 0.004 2.00 0.78 7.22 0.00 0.806
η 0.072 2.00 1.14 6.86 0.00 0.739 0.027 2.00 1.41 6.59 0.00 0.695
p = 20, q = 20
1st stage ζ 2.605 8.59 3.52 387.48 0.41 0.818 1.000 9.00 2.65 388.35 0.00 0.876
α 1.822 11.99 11.03 3776.97 0.01 0.720 0.836 12.00 3.91 3784.09 0.00 0.868
2nd stage γ 0.036 2.00 0.73 187.27 0.00 0.854 0.014 2.00 0.81 187.19 0.00 0.842
β 0.014 2.00 2.02 15.98 0.00 0.665 0.006 2.00 2.17 15.83 0.00 0.649
η 0.041 2.00 2.43 15.57 0.00 0.625 0.017 2.00 2.54 15.46 0.00 0.615
1SSE: Average sum of squared error across 100 simulations; 2TP: Average number of true positive
parameters across 100 simulations; 3FP: Average number of false positive parameters across 100
simulations;4 TN: Average number of true negative parameters across 100 simulations; 5 FN: Average
number of false negative parameters across 100 simulations; 6 MCC: Matthews correlation coefficient
a long-term natural history study of premanifest HD gene-positive subjects. Our analysis consisted
of 499 subjects who carried an expanded CAG repeats in the premanifest stage without an HD
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diagnosis at the baseline visit. The median follow-up length was 6.3 years. In our analyses, M i
includes baseline brain atrophy measures obtained from structural MRI. The regional subcortical
volumetric measures and cortical thickness measures were pre-processed using Freesurfer 5.3 and
the details were described in Paulsen et al. (2014). All volumetric measures were adjusted for total
intracranial volume. There were 6 subcortical ROI grey matter volumes and 18 cortical thickness
ROIs included in the analyses (see Appendix Table B4). These ROIs were selected from a marginal
screening (linear regression with second stage clinical measure as outcome) based on false discovery
rate corrected p-values.
The covariates Xi include 15 baseline clinical variables: CAP score which is a product of
CAG and age measuring disease burden (Zhang et al., 2011), four motor scores (bradykinesia,
rigidity, dystonia, chorea) from the Unified Huntington’s Disease Rating Scale (UHDRS), total
functional capacity (TFC), symbol digit modality test raw score (SDMT), three Stroop scores (color
naming, word reading, and interference), four verbal test scores, the University of Pennsylvania
smell identification test percentage of correct (smell identification test percent), and total grey
matter volume and total white matter volume. The second stage model outcome was the rate of
change in total motor score (TMS) estimated by a linear mixed-effects model with subject-specific
random intercepts and random slopes, treating time since baseline as the time scale and adjusting
for the baseline TMS.
In the first stage analyses of PREDICT-HD, we estimated the network structure and connec-
tion strength of cortical thickness and subcortical volumes separately under model (3.1). In the
second stage, we included covariates, subcortical volumes, cortical thickness and the subcortical
and cortical network connections obtained from the first stage to identify the important predictors
of the rate of change in TMS under model (3.3). Stability selection (Meinshausen and Bühlmann,
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2010) with 100 bootstraps was used to select informative network connections in the first stage
and important predictors in the second stage. For each bootstrap sample, ten-fold cross-validation
was applied to choose the optimal tuning parameter λ1 in the first stage. The selection rule of the
parameters in (ζj) and (αjk)j>k was based on the relative frequency among the 100 times boot-
strap. A variable would be selected if its relative frequency was larger than or equal to a threshold.
To reduce the risk of missing important connections in the first stage analysis, the threshold was
set at 0.5 (Meinshausen and Bühlmann, 2010). In the second stage, we constructed a set of 100
initial regularization parameters, denoted by Λ2, and performed variable selection on each λ2 ∈ Λ2.
Hard-thresholding was implemented and the total number of selected variables was set to be 100.
The final model was determined by the stability selection with a threshold of 0.65. We refitted the
models on the full data including only the identified predictors and network connections to provide
final parameter estimates.
3.4.1 First Stage Analysis Results
Among 270 potential parameters in the subcortical network, 150 were selected to be informative
(non-zero). For the cortical network, 908 out of 2,754 parameters were non-null. The average
cortical network identified in the first stage is visualized in Figure 3.4 (left panel). In this figure, the
strength of the edge between two ROIs represents the estimated partial correlation between them
for an “average” subject with covariates fixed at the sample averages. Two strongest connections
are the inter-hemispheric links between the left and right lateral occipital regions (contralateral
homologous regions) and between the left superior parietal and right superior frontal regions.
Among all covariates, the top three covariates with the largest total effects aggregated across
all cortical connections (based on the L2-norm) are bradykinesia score, smell identification test
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percent, and Stroop word reading score. The total effects of other covariates are summarized in
Appendix Table B5. The degrees (defined as the number of links between a target ROI and other
ROIs) of the cortical nodes for an average subject are visualized in Figure 3.3. The largest degree
(degree = 17) was seen in the right caudal anterior cingulate and left bankssts regions, whereas the
smallest degree (degree = 11) appeared in the left pars triangularis and left fusiform regions.
Figure 3.3: Degree of cortical nodes selected in the first stage for an average subject. Top row:
lateral view of left and right hemispheres; Bottom row: medial view of left and right hemispheres.
Color represents degree.
To understand the network organization of the cortical ROIs, they were classified into distinct
modules using the community Louvain algorithm based on the modularity optimization (Blondel
et al., 2008). The algorithm was performed on the connection matrix whose elements were the
absolute values of the estimated partial correlation. We repeated this algorithm 1,000 times and a
consensus clustering procedure was used to obtain a consensus partition (Lancichinetti and Fortu-
nato, 2012). These were implemented in the brain connectivity toolbox (BCT, version 2017-01-15,
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Rubinov and Sporns, 2010). We set the resolution parameter to represent the classic modularity.
Eighteen cortical thickness ROIs were classified into four modules (Figure 3.4, left panel: module 1
(blue nodes), left and right rostral middle frontal, left and right pars triangularis, and right caudal
anterior cingulate; module 2 (orange nodes), right superior frontal, left precuneus, left superior
parietal, left and right lateral occipital; module 3 (green nodes), left and right supramarginal, left
and right bankssts (i.e., cortical areas around superior temporal sulcus); module 4 (red nodes), left
inferior temporal, left fusiform, left and right lingual).
From the first-stage analysis, our conditional Gaussian graphical model reveals that the cortical
thickness network is dense but organizes in a modular fashion in premanifest HD, so that brain
regional cortical thinning acts in a dependent manner. The cortical “rich club” regions identified
in our grey matter structural network are classified to the same module as in the white matter
connectivity data (van den Heuvel and Sporns, 2011). Module 2 is almost consistent with cortical
“rich club” regions established in healthy human brains, which include the right and left superior
frontal, superior parietal, and precuneus regions, and the “rich club” regions are more connected to
each other than with other regions (van den Heuvel and Sporns, 2011). Selective loss of “rich club”
connectivity is an organizational principle of white matter connectivity loss in HD (McColgan et al.,
2015). In other modules, it can be seen that nodes in the same module fall into similar anatomical
regions. These results show that our network modularity is consistent with existing literature
when using the absolute value of partial correlation (and also mutual information) as a network
connection measure.
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First stage Second stage
Figure 3.4: Estimated cortical network (first stage) and effects of cortical connections on the rate of
change of the total motor score (second stage). In the left panel, edge color represents the estimated
partial correlation for an average subject (covariates fixed at the sample averages). Color of nodes
represents modular membership. In the right panel, edge color represents the estimated effect size
of the cortical connection on the rate of change of the total motor score. Blue nodes: cortical
thickness ROIs that are also selected in the second stage model; Black nodes: cortical thickness
ROIs themselves are not selected in the second stage model, but their connections are selected.
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3.4.2 Second Stage Analysis Results
Among all covariates Xi, CAP score and white matter total volumes are identified as informative
while none of the cognitive or functioning measures is identified given other variables in the final
model. Among subcortical measures, the volumetric ROIs are important for predicting TMS rate
of change, but not their network connections (only one connection was identified). In contrast,
cortical thickness network connections, instead of cortical thickness ROI measures, are identified
as important. Caudate, globus pallidus, and thalamus are selected among 6 subcortical volumes,
whereas right pars triangularis is the only one selected among 18 cortical thickness ROIs. The con-
nection between thalamus and globus pallidus regions is the only subcortical connection identified,
whereas 22 out of 153 cortical connections (Figure 3.4, right panel) are identified to be predictive
of motor symptom change.
The brain grey matter cortical thickness network identified in the first stage is dense (126 out
of 153 connections were identified for a population average subject). However, most of connections
do not predict TMS rate of change, which results in a sparse model in the second stage. The effect
size of each cortical connection is summarized in Appendix Table B6. Five cortical connections
most predictive of the motor symptom are the inter-hemispheric connections (Appendix Table B6).
Several anatomically long-distance connections are also identified, for example, the connection:
right lingual — right pars triangularis. In addition, most of the connections with positive effects
are the inter-hemispheric connections or anatomically long-distance connections.
Appendix Figure B3 shows the identified paths from a baseline covariate to the clinical motor
symptom through brain grey matter connections. We focus on four important baseline covariates:
CAP (CAG-age product), bradykinesia (measure of motor symptom severity), Stroop word read-
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ing (measure of cognition), and smell identification test percent (measure of cognitive state). The
paths between a covariate and brain network connections visualize the analyses results in the first
stage, which show that different brain connections are selectively related to different covariates.
Bradykinesia and smell identification test percent are associated with the largest number of brain
connections (10 connections) among the four covariates. The subcortical connection between hip-
pocampus and thalamus is associated with CAP, bradykinesia, and smell identification test percent
but not Stroop word test. The associations between subcortical connection and CAP and baseline
bradykinesia are consistent with the clinical consequences of the loss of indirect and direct basal
ganglia pathways in HD (hyperkinetic chorea and hypokinetic bradykinesia, respectively). In ad-
dition, Stroop word reading test is more associated with intra-hemispheric cortical connections (6
links) than inter-hemispheric cortical connection (only 1 link), while CAP almost equally affects
inter-hemispheric and intra-hemispheric cortical connections. As a measure of patient’s cognition,
the association between baseline Stroop word reading score and cortical connections instead of
subcortical connections is consistent with the existing literature (Rosas et al., 2008).
To assess the incremental predictive power of the selected ROIs and connections, we randomly
selected two thirds of subjects as a training set and the remaining one third subjects as testing data
and compared the R-squared value of the best performing model reported in the literature without
imaging measures (with covariates TMS, SDMT, and CAP; Long et al., 2017) with our model
including imaging biomarkers and their connections (i.e., TMS, SDMT, CAP, regional subcortical
volumetric and cortical thickness M i, subcortical and cortical connections W i). We repeated this
process 100 times. A ridge-penalty was imposed on cortical connections to minimize overfitting,
except for the connections between right superior frontal — left precuneus regions and left superior
parietal — left precuneus regions, which were identified in the previous literature (Chen et al.,
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2011). The average variance explained by the imaging biomarker model with cortical connections
was 30.1%, as compared to 25.7% of the standard non-imaging model. In Appendix B.4.1, we
also show that the imaging biomarker model improves the net reclassification rate for predicting
conversion to HD diagnosis.
3.4.3 Validation on TRACK-HD
We sought to validate findings from PREDICT-HD study on an independent natural history study
of HD, TRACK-HD (Tabrizi et al., 2009), that collected comprehensive grey matter and white
matter structural neuroimaging measures and clinical assessments of premanifest HD patients. The
cohort in the replication analyses includes 96 premanifest HD subjects with CAG repeat expansions.
The cohort was followed up at 4 time points (year 2008, 2009, 2010, and 2011) and the cortical
thickness ROIs were obtained from structural MRI and pre-processed by Freesurfer in a similar
fashion as PREDICT-HD. The details of study design and imaging measure pre-processing were
reported elsewhere (Tabrizi et al., 2009; McColgan et al., 2015, 2017b).
We evaluated the predictive performance of 22 cortical connections identified to be informative in
PREDICT on an independent study, TRACK-HD. First, we re-calibrated strength of the 22 cortical
connections identified in PREDICT on TRACK. Not all the measures used in the first-stage model
of the PREDICT analyses were available for TRACK. Thus, the subject-specific cortical connections
are estimated using baseline covariates CAP, SDMT, TFC, UHDRS diagnostic confidence level, and
Stroop word reading score. Similar to the PREDICT analyses, we compared the leave-one-out R-
squared value and mean squared error (MSE) of two linear models predicting TMS at the last visit:
a standard non-imaging model including baseline TMS and CAP score at the last visit as covariates,
and a brain grey matter imaging biomarker model additionally including the 22 estimated cortical
CHAPTER 3. IDENTIFYING DISEASE-ASSOCIATED BIOMARKER NETWORK
FEATURES THROUGH CONDITIONAL GRAPHICAL MODEL 52
connections. A ridge-penalty was imposed on cortical connections to minimize overfitting, except
for the connections between right superior frontal — left precuneus regions and left superior parietal
— left precuneus regions, which is the same as PREDICT analyses. Leave-one-out R-squared value
of the imaging model was 35.3% compared to the non-imaging model of 26.7%. Thus on the
independent TRACK-HD study, imaging biomarkers explained 0.32-fold additional variance of the
TMS. In addition, the decrease in the MSE of the imaging model was 13% (from 0.725 point/year to
0.641 point/year). The results show that the identified cortical connections are useful in predicting
follow up TMS in an independent HD study.
We also compared our method with FGL. The cohort was first classified into a high-risk class
and low-risk class based on median split of the CAP score. The 22 cortical connections were re-
calibrated through FGL with tuning parameters selected by AIC. The leave-one-out R-squared
value of the imaging biomarker model was only 28.1% and the mean squared error was 0.711
point/year, which suggests that using our method to estimate subject-specific connections explains
more variance in TMS.
3.4.4 Biological Implications and Insights
We compared the obtained grey matter networks with the white matter connectivity networks
obtained on the TRACK-HD (McColgan et al., 2017b). Two strongest connections identified in the
first stage model are consistent with McColgan et al. (2017b), showing that inter-hemispheric white
matter connections are particularly vulnerable in premanifest HD. In particular, McColgan et al.
(2015) found that degrees (number of brain connections) of the left superior frontal and left rostral
middle frontal regions were correlated with TMS. The identified grey matter modulars are also
similar to white matter modulars. In our study, among all cortical network connections identified
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in the first-stage, only a small percentage (17%) are associated with the clinical manifestation of
HD as measured by the rate of change in TMS. Long-range and inter-hemispheric links are more
likely to associate with motor impairment of HD, similar to the white matter connectivity study
in McColgan et al. (2017b). Only one connection in the subcortical regional volumetric network
was identified as informative of motor symptom. Stroop word reading was identified as one of the
top three most important covariates for cortical connections, which is consistent with Stout et al.
(2012). In addition, performance of the baseline Stroop word test is related to cortical connections
instead of subcortical connections, similar to the white matter connection study (McColgan et al.,
2017b).
The strong similarities seen between our grey matter connection study and the white matter
connectivity study (McColgan et al., 2017b) suggest a shared underlying mechanism of HD. These
findings are biologically important since they address a question that is still largely unknown in the
HD research community – is white matter loss a direct result of neuronal loss (i.e., caused by the
dying back of axons) as opposed to loss of myelin or dysmyelination. The shared pattern between
grey matter and white matter connectivity suggests the former.
We note the presence of both positive and negative cortical network connections in the first
stage results. These findings are in accordance with several previous studies of cortical thickness
co-variation patterns in normal subjects, aging adults, and patients with Alzheimer’s disease (Chen
et al., 2011; He et al., 2007, 2008). The distribution of the direction of network connections of our
results are similar to those of a previous age-related cortical thickness network study (Chen et al.,
2011): the number of connections with positive and negative effects on clinical outcome are the
same (positive/negative: 11/11), which is consistent with the age-related study in which the number
of increased and decreased correlation comparing normal aging network to young network were
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almost the same (decrease/increase: 17/16). In addition, the negative-effect connection between
the right superior frontal and left precuneus regions and the positive-effect connection between the
left superior parietal and left precuneus regions were also identified in Chen et al. (2011). Some
negative-effect connections are seen in frontal areas, which are also in accordance with Chen et al.
(2011).
3.5 Discussion
In this work, we propose a two-stage method to estimate a subject-dependent network from con-
ditional Gaussian graphical model and evaluate the incremental effect of the network measures on
a clinical outcome. Our method can simultaneously handle biomarkers and the between-subject
heterogeneity of the biomarker network measures using covariates.
Our analyses results suggest that brain cortical grey matter network connections are predictive
of HD motor impairment in addition to regional atrophy and other HD risk factors. Several exten-
sions can be considered. Including a positive-definite constraint to our algorithm will guarantee the
estimated subject-dependent precision matrix to be positive-definite, but at the cost of computa-
tional complexity. In our current method, we do not include such a constraint because our goal is to
extract useful features from the network to predict clinical outcomes instead of estimating the joint
distribution of biomarkers. The imaging biomarker model only explained about 35% variance of
the clinical manifestation (TMS) of HD in both PREDICT and TRACK. Substantial unexplained
variance suggests a need to identify other biomarker measures predictive of HD clinical phenotypes.




The symptoms of mental disorders are complex and often co-occur. Network approach has been
proposed recently to investigate the co-occurrence of symptoms, which attributes the cause of
co-occurrence to the direct interactions between symptoms rather than a common cause from a
latent disorder (Cramer et al., 2010; Borsboom, 2008; Borsboom and Cramer, 2013; Fried and
Cramer, 2017). The strength of the edge between two symptoms (nodes) is some measure of
statistical association between the two symptoms. Most studies focus on investigating the system
of psychiatric and psychological symptoms, such as depression symptoms. However, it has been
revealed that cognitive impairment is associated with depression symptoms (Fried and Nesse, 2014)
in major depressive disorder. It may be of interest to assess several kinds of symptoms instead of
symptoms from only one domain.
Considerable heterogeneity in patient’s symptoms is present in mental disorders (Olbert et al.,
2014; Galatzer-Levy and Bryant, 2013). Patients often differ in symptoms and behaviors, although
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they have the same diagnosis (Olbert et al., 2014). Subject’s risk factors (e.g., genetic variants,
age) may be relevant to the individual differences in symptom networks and influence the system
of symptoms in addition to the symptoms themselves (Borsboom, 2017; Fried and Cramer, 2017).
There is an urgent need to develop personalized assessment and treatments in mental disorders
(Fried and Cramer, 2017) and Fleeson et al. (2010) has suggested investigating the individual
difference in edge strength of symptom networks as a new research direction.
Regularized partial correlation networks, such as Gaussian graphical Lasso (glasso; Friedman
et al., 2008; Meinshausen and Bühlmann, 2006), have been predominantly used to study interactions
among symptoms using cross-sectional data, where each subject was measured once (Epskamp and
Fried, 2018). However, such approaches result in homogeneous network in one population and are
more informative to a group of subjects who have similar characteristics. When several distinct
subgroups are present in one population, the population-level network may not represent the true
subpopulation network. It may not provide clinically meaningful network over the whole population
if different subgroups have opposite associations between symptoms and the effect of association is
canceled out after averaging over the population.
When subgroups are known, glasso can be employed to construct the subgroup-specific network
for each subgroup separately. However, the estimated network may not be stable when the sample
size of subgroup is small (Epskamp et al., 2018). Fused graphical lasso (Danaher et al., 2014)
estimates multiple subgroup networks jointly to borrow shared characteristics among subgroups,
but still assumes that the subgroups are known. Some recent works have incorporated covariates
into the models by modeling the mean of nodes in the network as covariate-dependent but assume
a constant edge strength (Cai et al., 2012; Yin and Li, 2011; Chen et al., 2016). Cheng et al. (2014)
modeled the network using covariates but only for Ising model which is for binary variable nodes.
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In this work, we use the conditional Gaussian graphical model developed in Chapter 3 to
construct heterogeneous cross-sectional symptom networks. Sparse group lasso penalty and hard-
thresholding is used instead of using APM-L0 as introduced in Chapter 3. We use Bayesian in-
formation criterion (BIC) to choose the tuning parameters and hard-thresholding value, whereas
Chapter 3 employs cross-validation to choose the tuning parameter. The personalized symptom
network can inform treatment selection, for example choosing to treat the hub node symptoms.
4.2 Methods
Let Y i denote a vector of p-dimensional symptoms of the ith subject. LetXi denote a q-dimensional
vector of covariates (e.g., genetic variants, brain imaging biomarkers, treatment) of the ith subject.
Y i can include symptoms in different domains, Xi can include cortical and subcortical brain
atrophy volumetric measures at regions of interests (ROIs) available from structural magnetic
resonance imaging (MRI). The symptom network is defined as the precision matrix of Y i.
We use the conditional Gaussian graphical model discussed in Chapter 3 Section 3.2.1 for the
distribution of Y i given Xi. Then, the model can be expressed as
P (Y i|Xi) ∝ exp
(
ATi Y i −
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, αj = {αj1, . . . , αjq}T , and Ωi(j, j) = 1/σ2εj , Ωi(j, k) = Ωi(k, j) =
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and denote the log-pseudo likelihood function as ln(α,ω,σ
2) = logLn(α,ω,σ
2). The penalized





where p(ζ,α) is a properly chosen penalty function.
Here αj is a q-dimensional mean vector for node j and ωjk is a q-dimensional vector for edge
between nodes j and k, where each element in them corresponds to one covariate. Each vector αj
and ωjk can be treated as a group. We consider sparse group lasso penalty and use different tuning



















The networks might be still dense with sparse group lasso penalty. Hard-thresholding is further
imposed to remove the coefficients with small magnitude and BIC is used to choose both tuning
parameters λ1, λ2, and hard-thresholding values.
4.3 Simulation Studies
We evaluated our method under several simulation settings. Specifically, we varied the number of
sample size n, the number of symptoms p, the number of covariates q, and parameters α, ω, and σ2ε
of the precision matrix. In all settings, we simulated covariates Xi independently from a standard
normal distribution.
In Setting 1, p = q = 5 and we specified homogeneous variance parameters σ2εj = 0.2. The
α’s in the mean part and ω’s in the precision matrix were restricted to take values of 0, −1, or
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1. Specifically, α1 = α2 = (1, 1, 1, 0, 0)
T , α3 = (−1, 1, 1, 0, 0)T , and αj = 0 for j ∈ {4, 5}. ω11 =
(1, 1, 1, 0, 0)T , ω15 = (1, 1, 1, 0, 0)
T , ω23 = (−1, 1, 1, 0, 0)T , ω25 = (1, 1,−1, 0, 0)T , and ωjk = 0 for
the remaining parameters in ω. Setting 2 is the same as setting 1, but with heterogeneous variance
parameters σ2εj = 0.2 or 0.1. Setting 3 is the same as setting 1, but we allowed the nonzero values
of the ω’s to range from -1.5 to 1.5. Specifically, ω11 = (0.5, 1, 1.5, 0, 0)
T , ω15 = (1, 0.5, 1.5, 0, 0)
T ,
ω23 = (−1.5, 0.5, 1, 0, 0)T , and ω25 = (0.5, 1.5,−1, 0, 0)T . Setting 4 is also the same as Setting 1,
but we increased the number of symptoms p to 20. Setting 5 is the same as Setting 4, but the
number of covariates was increased to 10.
Each of the four settings was analyzed twice: once with n = 500, and once with n = 1000. We
compared our method with glasso. Hard-thresholding is also employed for glasso and BIC is used
to use the tuning parameter and hard-thresholding value. For each simulated data set, the length of
the grid search vectors of the tuning parameters λ1 and λ2 was 10 for our method, while the length
of the grid search vector for the single tuning parameter λ was 100 for glasso. The hard-thresholding
values are based on the convergence threshold log(p0)/
√
N up to a constant (Janková and van de
Geer, 2018), where p0 is the number of parameters in the model. Therefore, the hard-thresholding
value for our is C1 ∗ log(q ∗p∗(p−1)/2+q ∗p)/
√
N and that for glasso is C2 ∗ log(p∗(p−1)/2)/
√
N ,
where C1 and C2 are constants. We set the searching grid of C1 ranged from 1 to 1.5 by 0.1 for
Settings 1-3, from 1.2 to 1.5 by 0.05 for Setting 4 and Setting 5 when n=500, and from 1.25 to 1.5
by 0.05 for Setting 5 when n=1000. For glasso, the grid search for C2 ranged from 1 to 2 by 0.1.
Simulations were repeated 100 times for each setting.
Table 4.1 presents the performance of each setting in terms of estimating and selecting the
parameters in mean (α’s) and precision matrix (ω’s). For α’s, our method correctly identified all
9 truly positive parameters for a true positive rate (TPR) of 100% in all settings. In Setting 1
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with n = 500, of the 16 truly null parameters, our method on average selected 0.18 of them as
false positive. True negative rate (TNR) was best in Settings 4 and 5 with p = 20 (100%) and
worst in Setting 2 with heterogeneous variances (98.2%). All settings saw improved performance
when n = 1000. In terms of ω’s, in all but Setting 2, our method correctly identified all 12
truly positive parameters for a TPR of 100%. In Setting 1 with n = 500, of the 38 truly null
parameters, our method on average selected 0.2 of them as false positives. TNR was best in Setting
3 with heterogeneous nonzero ω values (99.6%) and worst in Setting 2 with heterogeneous variances
(97.7%). All settings saw improved performance when n = 1000.
We also evaluated the performance of identifying edges in the network (precision matrix) and
compared with glasso (Table 4.2). An edge between Mij and Mik is defined to exist if ||ωjk||2 6= 0.
Our method correctly identified all 4 truly positive edges for a TPR of 100% in all but Setting 2
and retained low false positive rate (FPR) of lower than 0.1% in all settings. For glasso, TPR was
about 80% for Settings 1 and 3, decreased to 0.7 for more complicated Settings 2 and 4, and further
decreased to 0.63 for Setting 5 with p = 20 and q = 10. High FPR of higher than 50% was seen
for Settings 1-3 and the low FPR for Settings 4 and 5 may due to a large number of parameters
existing in the precision matrix when p = 20. These results suggest that our method outperforms
glasso.
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Table 4.1: Estimation and Selection of Parameters: Performance of Simulations
n = 500 n = 1000
SSE1 TPR2 FPR3 TNR4 FNR5 SSE1 TPR2 FPR3 TNR4 FNR5
Setting 1. p = 5, q = 5, homogeneous α, ω, and σ2j
Mean (α) 0.243 1 0.011 0.989 0 0.174 1 0.006 0.994 0
Precision Matrix (ω) 0.184 1 0.005 0.995 0 0.106 1 0.001 0.999 0
Setting 2. p = 5, q = 5, heterogeneous σ2j
Mean (α) 0.274 1 0.018 0.982 0 0.189 1 0.012 0.988 0
Precision Matrix (ω) 1.09 0.967 0.023 0.977 0.033 0.603 0.999 0.02 0.98 0.0008
Setting 3. p = 5, q = 5, heterogeneous ω
Mean (α) 0.256 1 0.008 0.992 0 0.176 1 0.005 0.995 0
Precision Matrix (ω) 0.194 1 0.004 0.996 0 0.107 1 0.001 0.999 0
Setting 4. p = 20, q = 5
Mean (α) 0.335 1 0.0004 1.000 0 0.267 1 0.0003 1.000 0
Precision Matrix (ω) 4.48 1 0.020 0.980 0 1.45 1 0.012 0.988 0
Setting 5. p = 20, q = 10
Mean (α) 0.367 1 0.0003 1.000 0 0.223 1 0 1 0
Precision Matrix (ω) 4.46 1 0.009 0.991 0 2.03 1 0.008 0.992 0
1SSE: Average sum of squared error across 100 simulations; 2TPR: Average rate of true positive
parameters across 100 simulations; 3FPR: Average rate of false positive parameters across 100 simulations;
4 TNR: Average rate of true negative parameters across 100 simulations; 5 FNR: Average rate of false
negative parameters across 100 simulations
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Table 4.2: Estimation and Selection of Edges ωjk: Performance of Simulations
n = 500 n = 1000
TPR1 FPR2 TNR3 FNR4 TPR1 FPR2 TNR3 FNR4
Setting 1. p = 5, q = 5, homogeneous α, ω, and σ2j
Proposed method 1 0.028 0.972 0 1 0.002 0.998 0
glasso 0.805 0.855 0.145 0.195 0.882 0.907 0.093 0.118
Setting 2. p = 5, q = 5, heterogeneous σ2j
Proposed method 0.985 0.083 0.917 0.015 1 0.052 0.948 0
glasso 0.71 0.570 0.43 0.290 0.76 0.675 0.325 0.24
Setting 3. p = 5, q = 5, heterogeneous ω
Proposed method 1 0.015 0.985 0 1 0.005 0.995 0
glasso 0.8 0.718 0.282 0.2 0.84 0.782 0.218 0.16
Setting 4. p = 20, q = 5
Proposed method 1 0.085 0.915 0 1 0.053 0.947 0
glasso 0.7 0.025 0.975 0.3 0.768 0.030 0.970 0.232
Setting 5. p = 20, q = 10
Proposed method 1 0.071 0.929 0 1 0.067 0.933 0
glasso 0.63 0.025 0.975 0.37 0.68 0.030 0.970 0.32
1TPR: Average rate of true positive edges across 100 simulations; 2FPR: Average rate of false positive
edges across 100 simulations; 3 TNR: Average rate of true negative edges across 100 simulations; 4 FNR:
Average rate of false negative edges across 100 simulations
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4.4 Application to the Symptom Network of HD
Huntington’s Disease (HD), a progressive genetic neurodegenerative disease, is caused by an in-
herited CAG repeat expansion in the huntingtin gene and is characterized by motor (movement),
cognitive, and psychiatric symptoms. The symptoms can be represented by several subscores of
motor exams, cognitive tests, and psychiatric tests. The hallmark of the disease is the motor sign
of chorea which indexes the degree of abnormal involuntary movements. Slowness in execution
of movements (bradykinaesia), muscle contracture (dystonia), muscle rigidity, and abnormal eye
movements (oculo) are also common motor features in patients. Cognitive dysfunctions are mea-
sured by symbol digit modality test (SDMT), Stroop Color, Stroop test (Color, Word, Inference),
and smell identification test. Psychiatric symptoms may include depression, anxiety, interpersonal
sensitivity, which are assessed by the Symptom Checklist-90-R (SCL-90-R: a self-report psycho-
metric questionnaire), apathy, executive dysfunction, and disinhibition which are measured by a
self-report symptom inventory called Frontal System Behavioral Scale (FrSBe). Studies have shown
that the selective regional cortical thinning is related to symptoms and may explain the heterogene-
ity in symptoms (Rosas et al., 2008). However, it is unclear whether heterogeneous associations
between symptoms are modified by brain regional cortical thickness.
We analyzed the data from PREDICT-HD study (Paulsen et al., 2006) which is the largest
natural history study of HD. The subjects included in the analysis have at least two visits and the
number of subjects is 548 with median 3.96 of follow-up year. In the symptom network, five motor
symptoms (bradykinesia, chorea, dystonia, rigidity, oculo), six psychiatric symptoms (depression,
apathy, anxiety, sensitivity, disinhibition, executive), and five cognitive symptoms (SDMT, Stroop
Color, Stroop Word, Stroop interference, smell identification test) are the nodes. The covariates are
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CAP score which is a product of CAG and age, 16 baseline cortical thickness of regions of interest
(ROIs) which have demonstrated to be associated with HD, and caudate and putamen volume.
We constructed the network at the baseline visit. The nodes are the baseline symptom mea-
surements which have been standardized and the covariates have been standardized as well. We
compared the proposed method with glasso. We used the same tuning parameter λ for αj and
ωjk since both symptoms Y i and covariates Xi have been standardized and their scales are sim-
ilar. The length of the tuning parameter λ’s path for both methods is 100. The searching grid of
C1 for the proposed method is (0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5), while that for C2 in glasso is
(1.5, 1.6, 1.7, 1.8, 1.9, 2.0). BIC is used to choose the optimal λ and hard-thresholding value.
Figure 4.1 shows the networks identified by the proposed method and glasso at the baseline visit.
The symptoms which belong to the same clinical domain tend to form intra-domain subnetworks.
In the network of the proposed method (Figure 4.1, Left panel), the three movement symptoms
(chorea, oculo, bradykinaesia) are connected to each other, but not connected with muscle problems
(dystonia, rigidity). In the cognitive domain, SDMT and three Stroop scores are highly connected
whereas the smell identification test is isolated. This is not surprising because both SDMT and
Stroop test require visual scanning while smell identification test assesses the function of olfactory
system. The psychiatric subnetwork is the most dense one among the three domains, which suggests
more co-occurrence among psychiatric symptoms. Using the population-based method glasso, we
did not detect the co-variation between abnormal eye movement (oculo) and abnormal involuntary
movements (chorea) (Figure 4.1, Right panel).
We sought to validate the findings at the last visit (Figure 4.2). The symptoms were measured
at subjects’ last visit and the baseline covariates were used. At the last visit (Figure 4.2, Left
panel), the symptoms within the same domain co-occur more often. For example, it shows that
































Figure 4.1: Symptom Networks at baseline visit.
slowness in movement execution (bradykinaesia) is related to abnormal involuntary movements
(chorea). Subjects who are more anxious are also likely to have executive dysfunction. Many
connections in the last visit network identified by glasso (Figure 4.2, right panel) are different from
the baseline network identified by glasso. This result suggests that without adjusting for covariates,
glasso approach may be more at risk of identifying spurious edges. The graph correlation (Butts
et al., 2008) between the baseline network and last visit network identified by the proposed method
is 0.841 while that of glasso is 0.604.
The proposed method also identified the brain imaging biomarkers corresponding to each symp-
tom connections (Figure 4.3). The psychiatric domain connections varied by imaging biomarkers
whereas no imaging biomarker was detected to modify subject’s motor and cognitive domain con-
nections. The identified imaging biomarkers in rostral anterior cingulate and superior frontal regions
have been demonstrated to be associated with depressive symptoms in preHD subjects (McColgan
































Figure 4.2: Symptom Networks at the last visit. Red line: edge identified at baseline visit; Black
line: additional edge identified at last visit.
et al., 2017a; Koenigs and Grafman, 2009). Precuneus which controls emotion recognition and
cognitive processes, and cuneus which belongs to basic visual processing region are also identified
to be associated with psychiatric domain connections.
4.5 Discussion
In this work, we use the conditional Gaussian graphical model to capture the heterogeneity in
cross-sectional symptom networks. Symptoms in the same domain tend to form into the same
subnetwork. A dense psychiatric-domain network is identified, which suggests a treatment strategy
to focus on treating depression, sensitivity and executive problems (hub nodes) as target symptoms
to relieve psychiatric problems in HD patients. The personalized symptom networks can be used
to identify the target symptoms (with most connections to other symptoms) and further choose
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Figure 4.3: Edge corresponding imaging biomarkers at the baseline visit. Red: psychiatric domain.
individualized treatment based on each individual’s symptom networks. The validation on the
symptom network at the last visit shows that the networks at baseline visit and last visit are
similar but still present some differences. The current methodology can be extended to construct
heterogeneous temporal networks.
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Chapter 5
Integrative Network Learning for
Multi-modality Biomarker Data
5.1 Introduction
Although cortical thickness is regarded as an important early biomarker for disease progression,
especially for HD (Rosas et al., 2005, 2008), another neuroimaging modality used to investigate
structural connectivity is to reconstruct the trajectories of axonal fibers from white matter diffusion
tensor imaging (DTI) data using tractography for each individual. Both approaches are exploited
to understand the biologically meaningful characteristics of structural connectivity, and the grey
matter structural co-variance network and white matter connectivity from the two approaches
may arise from the same true underlying biological network. The regions physically connected
through white matter fibers may show stronger co-variation in their morphology. It has been
demonstrated that 30-40% of cortical thickness co-variance occurs between regions that exist white
matter connections (Alexander-Bloch et al., 2013a). White matter hyperintensities have also been
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shown to be associated with cortical thickness (Rizvi et al., 2018). Borrowing information from
the white matter connectivity network may yield a more reliable estimate of structural co-variance
network.
Several recent works have been proposed to estimate the functional connectivity from functional
MRI (fMRI) data by incorporating information from DTI data. Hinne et al. (2014) modeled the
posterior distribution of precision matrix for functional connectivity, assuming that the sparseness
structure of the precision matrix is given by white matter connectivity. This assumption is ex-
tremely restrictive since it assumes that functional connectivity exists only between regions that
show white matter connections. Adaptive gaussian graphical lasso models (Ng et al., 2012; Pineda-
Pardo et al., 2014) have been proposed to provide some room to allow the discordance between
functional connectivity and white matter connectivity, by using edge-specific shrinkage parameter
which is a function of fiber count between regions obtained from DTI data. However, such type
of shrinkage parameters is arbitrary, sensitive to the functional form, and also lacks biological in-
terpretation and meaning. In addition, these approaches do not account for the heterogeneity in
functional connectivity resulting from other sources of variations beyond white matter connectiv-
ity. Current studies (Gong et al., 2012) focus on estimating the structural co-variance network and
white matter connectivity separately and comparing their patterns. To the best of our knowledge,
no existing method has been exploited to estimate structural co-variance network by integrating
information from DTI data.
We propose a novel integrative learning approach for network estimation from multi-modality
biomarker data. Since grey matter structural changes are essential to our application, we will
focus on estimating grey matter structural co-variance network (target network), but leveraging
white matter connectivity network (external network) to borrow information and improve efficiency.
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Graphical models have been studied extensively to construct high-dimensional complex networks
(Friedman et al., 2008; Epskamp and Fried, 2018), where the connection strength between two
nodes represents the partial correlation between the two nodes conditioning on the remaining nodes.
However, gaussian graphical models assume a homogeneous network for subjects in a population. To
estimate subgroup-specific networks, a straightforward analysis is to estimate the network for each
subgroup separately by gaussian graphical models. Fused graphical lasso (Danaher et al., 2014)
has demonstrated better performance in estimating subgroup networks than gaussian graphical
models by jointly estimating networks for subgroups but assumes the subgroups are known. A
more flexible way is to consider modeling the connection strength as covariate dependent, resulting
in subgroup-specific networks automatically. However, none of these methods can incorporate prior
information from external modality.
Our integrative network learning uses a node-wise biomarker graphical model that builds on a
shared underlying biological network measured by multiple modalities. The approach improves the
network estimation of the target modality G∗ (i.e., structural co-variance network) and provides
subject- or subgroup-specific networks to capture the heterogeneity due to both subject’s covari-
ates and the networks of external modality G1 (i.e., white matter connectivity networks) which are
measured at the individual level. By including these individual networks to inform estimation of
structural co-variance network, the resolution of the latter network is expected to improve sub-
stantially. First, unobserved latent variables are introduced to represent the connections in the
true underlying shared biological network G0. The probabilities of connection in G0 is a function
of connections measured in the network of an external modality G1 based a network growth model
used to analyze brain networks (Vértes et al., 2012, a function of distance and degree). Second,
the connections between nodes in the target network G∗ is absent if there is no connection in the
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underlying true network G0. However, when there is a connection in G0, the connection in G∗ is still
allowed to be absent. This modeling framework captures the substantial but incomplete overlap
between G∗ and G1 of different modalities and also provides a biologically meaningful interpretation
that reflects G0. Next, we propose an EM algorithm to infer latent connection statuses in G0 from
the observed data in two modalities. Through these latent connections, the estimation of G∗ will
be improved by communicating with G1 through G0.
To use G0 and G1 to improve G∗, the posterior means of G0 given observations of nodes in both the
target and external graphs need to be computed. However, this is a highly challenging problem due
to the extensive number of potential connection patterns. For example, for a graph with p nodes,
the potential number of different combinations of latent connection statuses increases exponentially
with the graph size p and linearly with the sample size n (i.e., on the order of np(p−1)2p−2). When
the number of nodes increases, it is prohibitive to compute these posterior probabilities directly.
We propose an approximation approach to reduce the computational burden and running time.
We conduct simulation studies to examine the performance of the proposed method with varying
number of nodes and sample sizes and compare with gaussian graphical model. We apply the
method to an observational study of Huntington’s Disease, where both structural MRI (sMRI)
data and DTI data are available. We evaluate the clinical utility of the identified connections in
terms of both prediction and stratification in follow-up clinical outcomes. Incorporating connections
measured at baseline in linear regression model improves the prediction of the follow-up motor
outcomes, compared to standard covariate model and non-connection model which includes regional
nodes and covariates (but not connections between nodes). The clusters identified by connections
are more meaningful in distinguishing between cluster motor and cognitive outcomes than those
identified by regional nodes. We conclude the paper with some discussions and future directions.
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5.2 Methods
Our goal is to learn a covariate-dependent structural co-variance network using sMRI data by
incorporating white matter connectivity network features that are available from individual DTI
measurements. We assume that structural co-variance network and white matter connectivity arise
from the same underlying biological network. For the ith subject, let M i = (Mi1,Mi2, · · · ,Mip)′
denote measurements (centered at the mean) of sMRI markers in p brain regions (nodes). Let
Xi = (1, Xi1, Xi2, · · · , Xiq)′ denote a q + 1-dimensional vector including a constant of one and q






     (observed) 
External Network 
     (observed) 
Figure 5.1: Schematics of the proposed method.
5.2.1 Model
We consider a node-wise biomarker graphical model in which the connection between two nodes
depends on both observed variables Xi and an unobserved indicator of being connected in the
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shared biological network for each individual. The generative model is described in Figure 5.1. We
introduce latent variables Bijk to indicate the presence of an edge between nodes j and k (j 6= k)
in G0 for subject i, i.e., Bijk = 1 indicates that there is an edge. A subject-specific graphical model




θijkMik + εij , (5.1)
where θijk is modeled as θijk = 0 if Bijk = 0 and θijk = β
T
jkXi if Bijk = 1. Here εij is independent
of Mik and follows ∼ N(0, σ2j ). Note that βjk can still be zero if Bijk = 1. An edge between nodes
j and k is defined as present when ||βjk||2 6= 0 or ||βkj ||2 6= 0 and the proportion of Bijk = 1 over
all subjects is larger than a pre-specified value α. When Bijk are observed, the model reduces to a
covariate-dependent gaussian graphical model.
Since the probability of observing a connection (an edge) in the shared biological network is
unknown, we estimate it by conditioning on the white matter connectivity network. A partially
known network growth model which depends on the composite node degree (or the number of
nearest neighbors in common between two nodes) and distances between nodes (i.e. economical
clustering model (Vértes et al., 2012)) estimated from DTI white matter network is used to model
the pseudo probability of connection. The model was previously proposed to capture preferen-
tial attachment in social networks (e.g., rich gets richer, popular subject gets even more friends)
(Barabási and Albert, 1999). Human brain networks exhibit small-worldness, organizes in a modu-
lar fashion, and the hub nodes are in a fat-tailed degree distributions (Bullmore and Sporns, 2009;
He et al., 2007). To capture these observations, network growth models were recently used to model
the structural co-variation network using cortical thickness (He et al., 2007), fMRI data on healthy
subjects and Schizophrenia patients (Vértes et al., 2012), and DTI network (Betzel et al., 2016).
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Modeling network growth as a function of anatomical distance alone is insufficient to capture the
topological properties of functional brain networks and including an additional topological term
(e.g., composite node degree or the number of nearest neighbors in common between two nodes)
is more successful (Vértes et al., 2012). In addition, the degree distribution of the nodes in white
matter connectivity from DTI data in our real data application (Figure 5.2) is fat-tailed and shows
similar trend as the one generated by network growth model depending on a topological term, see
































Figure 5.2: Degree distribution of the nodes with Lowess smoothing density curve in white matter
connectivity network for an example subject.
Motivated from these prior studies, we obtain a pseudo probability of connection Bijk for node
pairs (j, k) as
pijk = P (Bijk = 1|sijk, dijk) =
(1 + sijk)
γd−ηijk




where sijk is the composite node degree (i.e., the product of node j’s degree and node k’s degree)
or the number of common neighbors of nodes j and k, and dijk is the anatomical distance between
nodes j and k in the white matter network of subject i. In this model, γ and η are usually non-
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negative. Thus, the probability of connecting two nodes in the biological network is increased when
they belong to a large white matter cluster (with a high degree), or when they are anatomically
close to each other (within a short distance).
There are several advantages of our modeling framework in (5.1) and (5.2). First, since model
(5.2) had biological underpinning, it improves biological relevance for the estimation of target net-
work G∗. The estimated connections in G∗ will reflect the anatomical distances and common neigh-
bors in G1. Second, by inferring Bijk as unknown latent connection statuses from observed data
M i, sijk, and dijk, we borrow information from networks measured by two neuroimaging modalities
and the efficiency can be improved. Third, regular analysis of covariate-dependent structural co-
variation networks is fitted at the subgroup level (depending on the resolution of covariates). In our
approach, since the DTI networks are measured for each individual, incorporating its information
into the estimation of θijk of structural MRI network improves resolution to the subject-level.
5.2.2 Estimation
For inference, we consider a node-wise conditional likelihood of the observed data at node j given the
other nodes, treating f({Bijk, k 6= j}|Di) as a prior distribution. Define Di = ({sijk}j,k, {dijk}j,k),
composite node degree and distance in DTI network. We assume that Bijk are independent for
nodes k’s given Di and we incorporate DTI network through these prior distributions. The pseduo-












































where n is the sample size.
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Treating Bijk as missing data, EM algorithm is used to estimate the parameters (β, σ
2
j , γ, η). An
advantage of incorporating DTI networks as prior information by introducing Bijk is to facilitate
the EM algorithm development: since the ”complete data” distribution gives a regular likelihood
so the EM ensures that the objective function increases over iterations. Next, we consider details
of the EM algorithm.
5.2.2.1 E-Step
In the E-step, we compute the expectation of the log pseudo complete data likelihood given observed




























































jk′Xi)MikMik′E(BijkBijk′ |Mij , Di).
To compute the above expected likelihood, we need obtain the posterior expectations of con-
nectivity indicators E[Bijk|Mij , Di] and E[BijkBijk′ |Mij , Di], which can be expressed as
E(Bijk|Mij , Di) = P (Bijk = 1|Mij , Di) =
P (Bijk = 1,Mij |Di)
P (Bijk = 1,Mij |Di) + P (Bijk = 0,Mij |Di)
,
E(B2ijk|Mij , Di) = E(Bijk|Mij , Di),
CHAPTER 5. INTEGRATIVE NETWORK LEARNING FOR MULTI-MODALITY
BIOMARKER DATA 77
and for k′ 6= k,
E(BijkBijk′ |Mij , Di) = P (Bijk = 1, Bijk′ = 1|Mij , Di)
=
P (Bijk = 1, Bijk′ = 1,Mij |Di)∑







































where b ∈ {1, 0} and bijl ∈ {1, 0} for l 6= j, k. In addition,





P (Bij1 = bij1, ..., Bijk = b, Bijk′ = b





































where b ∈ {1, 0}, b′ ∈ {1, 0} and bijl ∈ {1, 0} for l 6= j, k, k′.
The summation in P (Bijk = b,Mij |Di) and P (Bijk = b, Bijk′ = b′,Mij |Di) can be calculated
by (1) exhaustive enumeration (Direct); (2) Markov Chain Monte Carlo (MCMC); or (3) approx-
imation. The first two methods are computationally expensive and may not be feasible for large
networks. In this case, an approximation can be considered. Details of approximation are given
later in Appendix C.1.0.2.
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5.2.2.2 M-Step
In the M-step, we maximize the expected likelihood Qj replacing latent connections statuses by
their conditional expectations E(Bijk|Mij , Di) and E(BijkBijk′ |Mij , Di) computed from the E-step.
To estimate parameters γ and η under model (5.2), we perform a grid search to find the optimal
combination which results in the largest log pseudo complete data likelihood for node j and then
take the average over all the nodes. For each combination of γ and η, we maximize Qj and solve
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Iterations in the EM algorithm will terminate when the estimates of βjk’s and σ
2
j converge.
To remove spurious edges, hard-thresholding is performed on βjk based on EBIC criterion
(Foygel and Drton, 2011; Chen and Chen, 2008). EBIC for node j is defined as:
EBICj = −2 log(Lj(βjk, σ2j , γ̂, η̂)) + E × log(n) + 2δE × log(p− 1),
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where E is the number of non-zero ||βjk||2, δ is a hyperparameter, and γ̂ and η̂ are estimated from
EM algorithm. The estimates β̂jk and the corresponding σ̂
2
j that minimize EBICj are selected.
An edge between nodes j and k is defined as present when ||β̂jk||2 or ||β̂kj ||2 is non-zero and the
average of Ê(Bijk|Mij , Di) over all subjects is larger than a pre-specified value α.
5.3 Simulation Studies
5.3.1 Simulation Design
We conducted extensive simulations to evaluate the proposed method. We varied the number of
biomarker nodes, p = 5, 10 and the sample size, n = 200, 400 with the number of covariates q = 3.
We simulated covariates Xi independently from N(0.1, 1) truncated between -1 and 1. 4 out of 10




k and counted only once) are non-zeros
when p = 5 and 8 out of 45 βjk’s are non-zeros when p = 10. Two settings were considered:
Setting 1 (Weak signal):
• When p = 5, βTjk = (0.5,−0.5, 0.5) ∗ σ2j for (j, k) ∈ {(1, 2), (2, 1)}, β
T
jk = (0.5, 0.5,−0.5) ∗
σ2j for (j, k) ∈ {(1, 4), (4, 1)}, β
T
jk = (0.5, 0.5, 0.5) ∗ σ2j for (j, k) ∈ {(2, 3), (3, 2)}, β
T
jk =
(−0.5, 0.5, 0.5) ∗ σ2j for (j, k) ∈ {(2, 5), (5, 2)}, and σ22∗j−1 = 0.2, σ22∗j = 0.3 for j = 1, . . . , p;
• When p = 10, βTjk = (0.5, 0.5, 0.5)∗σ2j for (j, k) ∈ {(1, 3), (3, 1)}, β
T
jk = (−0.5, 0.5, 0.5)∗σ2j for
(j, k) ∈ {(1, 4), (4, 1), (2, 6), (6, 2)}, βTjk = (−0.5, 0.5,−0.5)∗σ2j for (j, k) ∈ {(2, 5), (5, 2), (9, 10), (10, 9)},
βTjk = (0.5,−0.5, 0.5) ∗ σ2j for (j, k) ∈ {(4, 5), (5, 4)}, β
T
jk = (0.5, 0.5,−0.5) ∗ σ2j for (j, k) ∈
{(6, 7), (7, 6), (8, 9), (9, 8)}, and σ22∗j−1 = 0.3, σ22∗j = 0.4 for j = 1, . . . , p.
Setting 2 (Strong signal):
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• When p = 5, βTjk = (1,−1, 1) ∗ σ2j for (j, k) ∈ {(1, 2), (2, 1)}, β
T
jk = (1, 1,−1) ∗ σ2j for
(j, k) ∈ {(1, 4), (4, 1)}, βTjk = (1, 1, 1) ∗ σ2j for (j, k) ∈ {(2, 3), (3, 2)}, β
T
jk = (−1, 1, 1) ∗ σ2j for
(j, k) ∈ {(2, 5), (5, 2)}, and σ22∗j−1 = 0.2, σ22∗j = 0.3 for j = 1, . . . , p ;
• When p = 10, βTjk = (1, 1, 1) ∗ σ2j for (j, k) ∈ {(1, 3), (3, 1)}, β
T
jk = (−1, 1, 1) ∗ σ2j for (j, k) ∈
{(1, 4), (4, 1), (2, 6), (6, 2)}, βTjk = (−1, 1,−1) ∗ σ2j for (j, k) ∈ {(2, 5), (5, 2), (9, 10), (10, 9)},
βTjk = (1,−1, 1)∗σ2j for (j, k) ∈ {(4, 5), (5, 4)}, β
T
jk = (1, 1,−1)∗σ2j for (j, k) ∈ {(6, 7), (7, 6), (8, 9), (9, 8)},
and σ22∗j−1 = 0.3, σ
2
2∗j = 0.4 for j = 1, . . . , p.
In the network of the external modality D, we let the edges (j, k) ∈ {(1,3), (3,1), (1,4), (4,1),
(2,3), (3,2), (2,4), (4,2), (2,5), (5,2)} be connected when p = 5 and (j, k) ∈ {(1,2), (2,1), (1,4),
(4,1), (2,3), (3,2), (2,5), (5,2), (2,6), (6,2), (5,6), (6,5), (6,7), (7,6), (6,8), (8,6), (7,8), (8,7), (7,9),
(9,7), (9,10), (10,9)} be connected when p = 10 for each subject. To add subject variation, there
exists an extra edge between nodes 4 and 5 if subjects have Xi1 > 0 and an edge between nodes 3
and 5 if subjects have Xi3 > 0. The distance between two nodes ranges from 0.1 to 2. We set the
degree parameter γ = 2 and the distance parameter η = 1.
We compared our method with EBIC glasso which is the gaussian graphical model with lasso
penalty and the tuning parameter is chosen by EBIC (Foygel and Drton, 2010). The edge selection
performance was assessed by AUC of varying both hard-thresholding values (or tuning parame-
ter in EBIC glasso) and the pre-specified proportion values α, the number of true positive (TP)
edges, number of false positive (FP) edges, number of true negative (TN) edges, number of false
negative (FN) edges, sensitivity and specificity. The lower and upper thresholds of E(Bijk|Mij , Di)
introduced in Appendix C.1.0.1 were set to be 0.1 and 0.9, respectively. We fixed η = 1 to save
computation time and selected Γ = {1.8, 1.9, 2.0, 2.1, 2.2} for grid search of γ. The number of hard-
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thresholding cutoff values is 50 and the values are based on the magnitude of β̂jk’s. The proportion
values α’s are {0, 0.1, 0.2, 0.3, 0.4}. The length of the searching path of the tuning parameter for
EBIC glasso is 50. We set the hyperparameter δ in EBIC formula to be 0.5, as suggested in previous
literature (Epskamp and Fried, 2018). In the approximation version of the proposed method, we
used the exponential basis functions with (λ1, ..., λ18)=(0.001, 0.002, 0.005, 0.02, 0.1, 0.2, 0.5, 1, 2,
3, 4, 5, 8, 10, 16, 25, 32, 64), generated ui uniformly in [-1.5, 1.5] and obtained the least square
estimates of the basis function coefficients ζ. The simulations were repeated 100 times.
5.3.2 Simulation Results
In Setting 1 with p = 5 (Figure 5.3, Top row, Left panel), the AUC of the proposed method with
direct calculation is 0.622 and that of using approximation is 0.621 when the sample size is 200. AUC
achieves 0.683 with direct calculation and 0.680 with approximation when the sample size increases
to 400. When p = 10 (Figure 5.3, Bottom row, Left panel), AUC=0.649 with direct calculation
and a similar AUC=0.650 with approximation when the sample size is 200. AUC increases to 0.754
with direct calculation and 0.752 with approximation as the sample size increases to 400.
Improvement of performance is seen when the signal is strong (Figure 5.3, Right panel). When
p = 5 (Figure 5.3, Top row, Right panel), the AUCs of the proposed method are close to 0.8 (direct
calculation: AUC=0.784, approximation: AUC=0.781) when the sample size is 200, and they are
above 0.9 (direct calculation: AUC=0.908, approximation: AUC=0.906) when the sample size is
400. When p = 10 (Figure 5.3, Bottom row, Right panel), the AUCs of the proposed method
are above 0.9 (direct calculation: AUC=0.906, approximation: AUC=0.919) when the sample
size is 200, and they increased to above 0.97 (direct calculation: AUC=0.976, approximation:
AUC=0.978) when we increased the sample size to 400. The AUCs of the EBIC glasso for all
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Setting 1: Weak Signal Setting 2: Strong Signal
p = 5, n = 200 p = 5, n = 400 p = 5, n = 200 p = 5, n = 400
































































p = 10, n = 200 p = 10, n = 400 p = 10, n = 200 p = 10, n = 400
































































Figure 5.3: ROC curves of the simulations. Black solid line: Proposed Method (Direct); Red
long-dash line: Proposed Method (Approximation); Blue dash line: EBIC glasso.
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settings are around 0.5 and at most 0.6.
Table 5.1 shows the selection performance of the simulation studies when p = 5. In Setting 1
where the signal is difficult to detect, the sensitivity of the proposed method is about 30% while
that of EBIC glasso is only about 3%. In Setting 2 (strong signal), the proposed method can
identify about 3 TPs with sensitivity larger than 70% compared to EBIC glasso with sensitivity 4%
when the sample size is 200. The proposed method can almost identify all the TPs with sensitivity
93.3% and reasonable numbers of TNs with specificity around 73%, whereas the sensitivity of EBIC
glasso is only 4.5% when the sample size is 400.
Similar results are seen when p = 10 (Table 5.2). In Setting 1, the sensitivity of the proposed
method is about 30% while that of EBIC glasso is just 0.6% when n = 400. When we have strong
signals, the proposed method can almost identify all the TPs while EBIC glasso hardly detects
the signals with 0.27 TPs when n = 200 and with 0.44 TPs when n = 400. The sensitivity of
the proposed method achieves 87.8% when n = 200 and 98.9% when n = 400, meanwhile, the
specificity keeps at 77.4% when n = 200 and 84% when n = 400.
The major difference between the proposed method and EBIC glasso is that EBIC glasso es-
timates the edge strength between two nodes at the population level and does not account for
covariate-dependent or subject-specific connection status. When Bijk = 1, θijk = β
T
jkXi can be
either positive or negative depending on covariates Xi. When Bijk = 0, θijk = 0 directly. There-
fore, the average edge signal at the population is low for many edges. These may explain the poor
performance of EBIC glasso.
The EM algorithm generally converged in 100 iterations for each γ, otherwise it tended to
diverge. To reduce computation time, we set the maximum iteration number to be 100. If EM did
not converge in 100 iterations for a node under the optimal γ, we re-selected γ among the converged
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Table 5.1: Selection Performance of Simulations for p = 5.
Proposed Method EBIC glasso
α = 0 α = 0.1 α = 0.2 α = 0.3 α = 0.4 α = 0 α = 0.1 α = 0.2 α = 0.3 α = 0.4
Direct Approx. Direct Approx. Direct Approx. Direct Approx. Direct Approx.
Setting 1: Weak Signal
n=200
TP 1 1.19 1.03 1.19 1.03 1.19 1.03 1.19 1.03 1.19 1.03 0.11 0.11 0.11 0.11 0.11
FP 2 1.07 0.98 1.07 0.98 1.07 0.98 1.07 0.98 0.64 0.62 0.12 0.12 0.12 0.12 0.12
TN 3 4.93 5.02 4.93 5.02 4.93 5.02 4.93 5.02 5.36 5.38 5.88 5.88 5.88 5.88 5.88
FN 4 2.81 2.97 2.81 2.97 2.81 2.97 2.81 2.97 2.81 2.97 3.89 3.89 3.89 3.89 3.89
Sensitivity 6 0.298 0.258 0.298 0.258 0.298 0.258 0.298 0.258 0.298 0.258 0.028 0.028 0.028 0.028 0.028
Specificity 7 0.822 0.837 0.822 0.837 0.822 0.837 0.822 0.837 0.893 0.897 0.980 0.980 0.980 0.980 0.980
n=400
TP 1 1.35 1.28 1.35 1.28 1.35 1.28 1.35 1.28 1.35 1.28 0.13 0.13 0.13 0.13 0.13
FP 2 0.84 0.80 0.84 0.80 0.84 0.80 0.84 0.80 0.45 0.43 0.19 0.19 0.19 0.19 0.19
TN 3 5.16 5.20 5.16 5.20 5.16 5.20 5.16 5.20 5.55 5.57 5.81 5.81 5.81 5.81 5.81
FN 4 2.65 2.72 2.65 2.72 2.65 2.72 2.65 2.72 2.65 2.72 3.87 3.87 3.87 3.87 3.87
Sensitivity 6 0.338 0.320 0.338 0.320 0.338 0.320 0.338 0.320 0.338 0.320 0.033 0.033 0.033 0.033 0.033
Specificity 7 0.860 0.867 0.860 0.867 0.860 0.867 0.860 0.867 0.925 0.928 0.968 0.968 0.968 0.968 0.968
Setting 2: Strong Signal
n=200
TP 1 3.03 2.84 3.03 2.84 3.03 2.84 3.03 2.84 3.03 2.84 0.16 0.16 0.16 0.16 0.16
FP 2 1.81 1.72 1.81 1.72 1.81 1.72 1.81 1.72 1.29 1.17 0.11 0.11 0.11 0.11 0.11
TN 3 4.19 4.28 4.19 4.28 4.19 4.28 4.19 4.28 4.71 4.83 5.89 5.89 5.89 5.89 5.89
FN 4 0.97 1.16 0.97 1.16 0.97 1.16 0.97 1.16 0.97 1.16 3.84 3.84 3.84 3.84 3.84
Sensitivity 6 0.758 0.710 0.758 0.710 0.758 0.710 0.758 0.710 0.758 0.710 0.040 0.040 0.040 0.040 0.040
Specificity 7 0.698 0.713 0.698 0.713 0.698 0.713 0.698 0.713 0.785 0.805 0.982 0.982 0.982 0.982 0.982
n=400
TP 1 3.73 3.73 3.73 3.73 3.73 3.73 3.73 3.73 3.73 3.73 0.18 0.18 0.18 0.18 0.18
FP 2 1.65 1.61 1.65 1.61 1.65 1.61 1.65 1.61 1.07 1.00 0.17 0.17 0.17 0.17 0.17
TN 3 4.35 4.39 4.35 4.39 4.35 4.39 4.35 4.39 4.93 5.00 5.83 5.83 5.83 5.83 5.83
FN 4 0.27 0.27 0.27 0.27 0.27 0.27 0.27 0.27 0.27 0.27 3.82 3.82 3.82 3.82 3.82
Sensitivity 6 0.933 0.933 0.933 0.933 0.933 0.933 0.933 0.933 0.933 0.933 0.045 0.045 0.045 0.045 0.045
Specificity 7 0.725 0.732 0.725 0.732 0.725 0.732 0.725 0.732 0.822 0.833 0.972 0.972 0.972 0.972 0.972
1TP: Average number of true positive parameters across 100 simulations; 2FP: Average number of false
positive parameters across 100 simulations; 3 TN: Average number of true negative parameters across 100
simulations; 4 FN: Average number of false negative parameters across 100 simulations; 5: Average false
discovery rate across 100 simulations; 6: Average sensitivity across 100 simulations; 7: Average specificity
across 100 simulations.
values for the diverging nodes.
5.3.3 Computational Advantage of the Approximation
The results of the proposed method with approximation are comparable to those of direct calcula-
tion when the sample size is 200, and they are very similar when the sample size is 400, in terms of
both selection performance in the final model (Tables 5.1 and 5.2) and ROC curves (Figure 5.3).
Although losing some accuracy with low sample size, computational efficiency is gained when we
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Table 5.2: Selection Performance of Simulations for p = 10.
Proposed Method EBIC glasso
α = 0 α = 0.1 α = 0.2 α = 0.3 α = 0.4 α = 0 α = 0.1 α = 0.2 α = 0.3 α = 0.4
Direct Approx. Direct Approx. Direct Approx. Direct Approx. Direct Approx.
Setting 1: Weak Signal
n=200
TP 1 1.72 1.65 1.72 1.65 1.72 1.65 1.72 1.65 1.64 1.57 0.04 0.04 0.04 0.04 0.03
FP 2 4.13 3.61 4.13 3.61 4.13 3.61 4.13 3.61 2.93 2.55 0.12 0.12 0.12 0.12 0.12
TN 3 32.87 33.39 32.87 33.39 32.87 33.39 32.87 33.39 34.36 34.74 36.88 36.88 36.88 36.88 37.17
FN 4 6.28 6.35 6.28 6.35 6.28 6.35 6.28 6.35 6.07 6.14 7.96 7.96 7.96 7.96 7.67
Sensitivity 6 0.215 0.206 0.215 0.206 0.215 0.206 0.215 0.206 0.211 0.203 0.005 0.005 0.005 0.005 0.005
Specificity 7 0.888 0.902 0.888 0.902 0.888 0.902 0.888 0.902 0.921 0.932 0.997 0.997 0.997 0.997 0.997
n=400
TP 1 2.84 2.35 2.84 2.35 2.84 2.35 2.84 2.35 2.76 2.28 0.05 0.05 0.05 0.05 0.05
FP 2 3.23 2.72 3.23 2.72 3.23 2.72 3.23 2.72 2.12 1.84 0.23 0.23 0.23 0.23 0.23
TN 3 33.77 34.28 33.77 34.28 33.77 34.28 33.77 34.28 35.10 35.38 36.77 36.77 36.77 36.77 36.99
FN 4 5.16 5.65 5.16 5.65 5.16 5.65 5.16 5.65 5.02 5.50 7.95 7.95 7.95 7.95 7.73
Sensitivity 6 0.355 0.294 0.355 0.294 0.355 0.294 0.355 0.294 0.356 0.294 0.006 0.006 0.006 0.006 0.006
Specificity 7 0.913 0.926 0.913 0.926 0.913 0.926 0.913 0.926 0.943 0.951 0.994 0.994 0.994 0.994 0.994
Setting 2: Strong Signal
n=200
TP 1 7.02 5.92 7.02 5.92 7.02 5.92 7.02 5.92 6.76 5.72 0.27 0.27 0.27 0.27 0.22
FP 2 8.36 5.91 8.36 5.91 8.36 5.91 8.36 5.91 6.47 4.67 0.33 0.33 0.33 0.33 0.38
TN 3 28.64 31.09 28.64 31.09 28.64 31.09 28.64 31.09 30.84 32.64 36.67 36.67 36.67 36.67 36.93
FN 4 0.98 2.08 0.98 2.08 0.98 2.08 0.98 2.08 0.93 1.97 7.73 7.73 7.73 7.73 7.47
Sensitivity 6 0.878 0.740 0.878 0.740 0.878 0.740 0.878 0.740 0.878 0.746 0.034 0.034 0.034 0.034 0.030
Specificity 7 0.774 0.840 0.774 0.840 0.774 0.840 0.774 0.840 0.827 0.875 0.991 0.991 0.991 0.991 0.990
n=400
TP 1 7.91 7.69 7.91 7.69 7.91 7.69 7.91 7.69 7.58 7.36 0.44 0.44 0.44 0.44 0.42
FP 2 5.91 5.31 5.91 5.31 5.91 5.31 5.91 5.31 4.28 3.86 0.52 0.52 0.52 0.52 0.54
TN 3 31.09 31.69 31.09 31.69 31.09 31.69 31.09 31.69 33.05 33.46 36.48 36.48 36.48 36.48 36.79
FN 4 0.09 0.31 0.09 0.31 0.09 0.31 0.09 0.31 0.09 0.31 7.56 7.56 7.56 7.56 7.25
Sensitivity 6 0.989 0.961 0.989 0.961 0.989 0.961 0.989 0.961 0.988 0.960 0.055 0.055 0.055 0.055 0.055
Specificity 7 0.840 0.856 0.840 0.856 0.840 0.856 0.840 0.856 0.886 0.897 0.986 0.986 0.986 0.986 0.986
1TP: Average number of true positive parameters across 100 simulations; 2FP: Average number of false
positive parameters across 100 simulations; 3 TN: Average number of true negative parameters across 100
simulations; 4 FN: Average number of false negative parameters across 100 simulations; 5: Average false
discovery rate across 100 simulations; 6: Average sensitivity across 100 simulations; 7: Average specificity
across 100 simulations.
use approximation to calculate the posterior expectations (Table 5.3) in all cases. All calculations
were carried out on an Intel Core i7 2.8 GHz processor. The average running time per simulation
of using approximation reduces by about 50% when n = 200 compared to the direct calculation.
The approximation approach costs similar time for n = 400 and n = 200, thus the running time
reduces by more than 66% compared to direct calculation when n = 400.
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Table 5.3: Average Running Time for One Simulation Using Direct Calculation and Approximation.
Direct Approx.
weak signal strong signal weak signal strong signal
p = 5, n = 200 2.838 secs 2.730 secs 0.923 secs 1.202 secs
p = 5, n = 400 5.517 secs 5.035 secs 1.546 secs 1.618 secs
p = 10, n = 200 4.767 mins 5.269 mins 2.079 mins 2.907 mins
p = 10, n = 400 7.516 mins 7.798 mins 1.683 mins 2.608 mins
5.4 Application to the Grey Matter Atrophy Network of HD
Huntington’s Disease (HD), a progressive genetic neurodegenerative disease, is caused by an inher-
ited CAG repeat expansion in the huntingtin gene and is characterized by cognitive, motor and
psychiatric symptoms (Paulsen et al., 2008, 2006; Klöppel et al., 2015). Studies have shown that
cortical thinning begins a decade before disease onset (Rosas et al., 2005; Tabrizi et al., 2009). The
grey matter structural co-variance networks are reported to differ among healthy controls, preHD,
and HD patients, and might be an early biomarker for HD (Coppen et al., 2016). Our goal is
to enhance estimation of the grey matter structural co-variation network of the rate of change in
cortical thickness using information from white matter connectivity network in HD patients.
We analyzed data collected from an international longitudinal natural history study of HD,
TRACK-ON (Klöppel et al., 2015). The cohort in the analyses includes 87 premanifest HD (preHD)
patients who carried mutant gene but not yet diagnosed, and was followed up at 3 time points (year
2012, 2013, and 2014). The grey matter cortical thickness regions of interest (ROIs) were obtained
from structural MRI data and generated by segmenting a T1-weighted image by Freesurfer (Desikan
et al., 2006). White matter connections for each individual were available from DTI data, and the
connection strength between ROIs was the weighted streamline counts, resulting from probabilistic
tractography. Details of the study design and MRI data acquisition can be found in McColgan
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et al. (2017b).
With longitudinal DTI measurements available, a linear mixed-effects model was used to com-
pute the rate of change in connections between ROIs and their p-values, after adjusting for the
baseline connection, CAG, age, gender, baseline total motor score (TMS), baseline symbol digit
modalities test (SDMT) score which reflects cognitive ability, and baseline total functional capacity
(TFC) which measures progressive functional decline.
A previous white matter connectivity study (McColgan et al., 2017b) using TRACK-ON has
demonstrated that preHD subjects have significantly more vulnerable connections compared with
controls in the left and right posterior motor-occipital parietal modules. In the white matter
connection networks, the nodes are the ROIs which have at least one connection with the false
discovery rate (FDR) correction q < 0.1 and within the two modules. If the connection strength
between nodes j and k for subject i is also non-zero at the baseline visit, the edge between nodes
j and k is defined as present in subject i’s white matter connection network. For each individual,
the white matter structural connectivity network consists of 10 nodes (ROIs) and at most 8 edges
(Table C1). The anatomical distances between ROIs were obtained from a template and were the
euclidean distances. The distances ranged from 14 to 88 and we scaled the distance by dividing by
150. As a preliminary analysis to obtain good initial values, we fitted a logistic regression model
using product of degrees and distance as covariates on white matter network and obtained the
estimated parameters γ̂ = 0.44 and η̂ = 0.31. Thus, we set the searching path for γ to be {0.2, 0.3,
0.4, 0.5, 0.6} and η to be {0.15, 0.20, 0.25, 0.30, 0.35}.
The same 10 ROIs are used in the cortical grey matter structural co-variation network. The
nodes are the rates of change in cortical thickness ROIs estimated by a linear mixed-effects model
adjusting for the baseline cortical thickness. The proposed method identified 22 connections while
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EBIC glasso identified 12 connections (Appendix C.2, Table C1) when setting the length of the
path of hard-thresholding values in the proposed method or tuning parameters in EBIC glasso to be
50, proportion value α = 0, and hyperparameter δ = 0.5. Four connections (right lateral occipital -
right supramarginal, left precuneus - left precuneus, right supramarginal - right paracentral, right
supramarginal - right precuneus) were identified by both methods. Five connections (right cuneus
- right lateral occipital, left precuneus - right paracentral, left precuneus - right pericalcarine,
right isthmuscigulate - right precuneus, right isthmuscingulate - left paracentral) identified by the
proposed method in the grey matter network were in common with the white matter connection
network, whereas only one connection (left precuneus - right supramarginal) identified by EBIC
glasso in the grey matter network overlapped with the white matter connection network.
5.4.1 Clinical Utility of the Connections
To assess the clinical utility of the identified connections by integrative network learning, we eval-
uated their associations with TMS at the last visit, which is a measure of motor symptom, the
hallmark of HD. We compared the R-squared values of the linear regression models of standard
covariate model (with covariates CAP (age×(CAG-35.5)), baseline SDMT, baseline TMS), non-
connection imaging model (with covariates and 10 regional cortical thickness ROIs), and the con-
nection imaging model (with covariates, 10 regional cortical thickness, and identified connections




j ∗ Ê(Bijk|Mij , Di) was treated as the connection
strength between ROIs j and k. The R-squared value of the standard covariate model is 0.376 and
it increases to 0.494 when incorporating regional cortical thickness. Additional 13.7% of variance
is explained by the connection imaging model (R-squared value = 0.631). Note that the network
is constructed without using the motor symptoms. These results suggest that the identified con-
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nections are highly predictive of the future motor symptom outcomes after including standard
measures and regional cortical thickness.
The connections identified by the proposed method are comparable to those reported in pre-
vious literature. The connection between precuneus and isthmus cingulate regions, identified in
both the structural co-variation network and white matter connectivity, has been showed to have
greater functional connectivity in preHD subjects compared to control in a recent fMRI study on
TRACK-ON (McColgan et al., 2017a). The thickness of occipital regions, which are important
visual processing regions, including the cuneus and lateral occipital, has been found to impact
cognition (Rosas et al., 2008; Johnson et al., 2015). The precuneus which responds to a range of
cognitive processes and the paracentral region have been demonstrated to be correlated with cog-
nitive performance (Rosas et al., 2005, 2008). These regions with similar functions might co-vary
as well.
5.4.2 Clustering Analysis Based on Connectivity Measures
We show another utility of the identified connections in stratifying patients into homogeneous
groups of clinical outcomes. The connections show greater between-subject discriminative power
and tend to cluster patients into groups (Figure 5.4, Left panel), whereas no clear cluster is seen
in the heatmap of the regional nodes (Figure 5.4, Right panel). Furthermore, we conducted k-
means clustering analysis based on the connectivity identified by the proposed method and the
regional nodes separately. We chose the number of clusters to be 4 since the elbow points for both
connectivity and regional nodes are at cluster=4 (Figure 5.5). ANOVA F test was conducted to
test the differences between the TMS at the last visit and SDMT at the last visit of the identified
four subgroups based on connectivity and regional nodes. There is a significant group difference
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for connectivity-based clusters (Figure 5.6, Left panel), while no significant difference for regional
nodes based clusters (Figure 5.6, Right panel). The connectivity can better stratify subjects into


































Figure 5.4: Heatmaps of connectivity and nodes. Each column represents one subject and each row
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Optimal number of clusters
Figure 5.5: Elbow plots of connectivity and nodes
5.5 Discussion
In this work, we propose an integrative network learning method under a pseudo-likelihood graphical
model to improve the estimation of a target covariate-dependent network. Our method exploits the











































































TMS last visit SDMT last visit TMS last visit SDMT last visit
p-value= 6.28e-08 p-value= 0.00315 p-value= 0.233 p-value= 0.914
Figure 5.6: Clustering analysis based on connectivity and nodes
shared mechanism between different domains when multiple modalities of biomarkers are available.
The network information of the external modality is treated as prior information to model the shared
biological network. Network growth model which captures the small-worldness and fat-tailed degree
distribution properties in human brain networks has been used to generate the biological network.
Our method creates new useful network measures (connectivity) to improve prediction in clinical
outcomes and better stratify subjects into homogeneous groups. Thus, the connectivity measures
might be considered to be included as new biomarkers to recruit subjects for future clinical trials.
Several extensions can be considered. We can consider generalizing to use the power prior
(Ibrahim et al., 2000; Spiegelhalter et al., 2004) in equation (5.3), i.e., f({Bijk, k 6= j}|Di) is raised
to some power, where the power is tuned to determine how much information can be borrowed
from the DTI network. The current approximation approach may not be directly applicable to
large networks and other faster computational techniques might be considered to further improve
computation, for example, variational Bayes approximation.
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Chapter 6
Conclusions
This dissertation develops several statistical methods to approximate `0-penalty efficiently and con-
struct biomarker networks accounting for subjects’ characteristics captured by subject’s covariates
and additionally prior individual-level network information when external biomarker modality is
available. These methodologies are also used to construct personalized symptom networks.
In Chapter 2, we propose a computationally efficient two-stage algorithm (i.e., APM-L0) to
regularize `0-norm as closely as possible. The algorithm can be regarded as a regularized regression
in the first stage and followed by a step of hard-thresholding based on the magnitude of estimates in
the first stage. The algorithm is inspired by ADMM, but we optimize on a non-convex function (i.e.,
`0-norm) of surrogate parameter while ADMM requires the function of surrogate parameter to be
convex. In addition, we treat step sizes as tuning parameters and use cross-validation to determine
their values compared to ADMM using Lagrange equations to determine them. We further develop
a one-step coordinate descent algorithm accounting for the sparsity structure in the first stage
to reduce memory usage and running time. The method allows different types of convex penalty
in the first stage (e.g., `1-penalty, `2-penalty, Elastic Net, Sparse group lasso, Laplacian penalty)
and is flexible enough for a variety of models (e.g., linear model, cox proportional hazards model,
or graphical model). We demonstrate the superior performance of APM-L0 in terms of selection
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accuracy and computational efficient as compared to existing methods through simulations and
real data application.
In Chapter 3, we develop a two-stage method to construct heterogeneous biomarker networks
and evaluate the associations between network connections and disease clinical outcomes. The first
stage model is a conditional Gaussian graphical model to estimate subject- or subgroup-specific
networks by incorporating subject’s covariates to model the connection strength. APM-L0 is used
to handle the high-dimensional parameter space in the graphical model. In the second stage,
the estimated network connections are included as subject’s features with covariates and regional
biomarker nodes in the regularized regression to evaluate their clinical utility. The advantages of
this method are (1) we do not require that subgroups are known. Modeling the edge strength as a
function of covariates automatically forms subgroups and also borrows strength from the population;
(2) the subject-specific network connections can be potential new biomarkers to predict disease
progression. We assess the performance of the proposed method to an application to an HD study
and validate the findings in an independent HD study. We demonstrate that cortical network
connections are predictive of clinical motor function deterioration, whereas regional subcortical
volumes instead of subcortical connections are identified to predict it. In addition, we address an
important biological question of HD: whether white matter loss is a direct result of neuronal loss
or the loss of myeline. Our results support the prior one.
In Chapter 4, we use the conditional Gaussian graphical model developed in Chapter 3 to
estimate heterogeneous cross-sectional symptom networks in order to investigate the co-occurrence
of symptoms. Compared to Chapter 3, we use sparse group lasso penalty with hard-thresholding
and BIC is used to choose the tuning parameters. We apply this method to an HD study and
validate the findings of baseline networks at the last visit. We show that symptoms in the same
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clinical domain tend to fall into the same subnetworks.
In Chapter 5, we extend the methodology in Chapter 3 to improve the estimation of target
network by borrowing information from external modality. We introduce latent variables to exploit
the shared mechanism between target network and external network, and also allow the room to
capture the incomplete overlap between them. The estimation of subject-specific target network can
be more reliable by incorporating individual-level external network information besides subject’s
covariates alone. We apply the methodology to a HD study and find that the identified network
connections can help in predicting future clinical outcomes and better stratify subjects into clinically
meaningful groups for recruitment in future clinical trials.
One limitation of our current approach to estimate the conditional Gaussian graphical model
is that we do not impose the positive-definite constraint on the precision matrix because our goal
is to create new features from the network to improve prediction of clinical outcomes rather than
estimating the joint distribution of nodes. Imposing constraint can be achieved by replacing current
neighborhood selection method with global likelihood based approach along the line of graphical
lasso (Friedman et al., 2008). However, the computational complexity will increase. In terms of
the applications, the imaging biomarker model only explains about 35% of variance in clinical
outcome (TMS) in HD, which suggests the need to identify other biomarkers. For the integrative
network learning method introduced in Chapter 5, the current approximation approach may not be
directly applicable to large networks and other computational techniques, for example, variational
Bayes approximation, might be considered to improve computation. In addition, our methods are
currently implemented on a single core. Node-wise parallel computing can be exploited to construct
large networks.
Several extensions can be considered. We can consider using other shrinkage methods, for
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example, SCAD, in the first stage of APM-L0 introduced in Chapter 2. For the subject-specific
graphical models developed in Chapters 3, 4, and 5, we assume that the variation among network
connections between subjects is fully explained by exogenous covariates. However, in practice
it is possible that residual heterogeneity is present. Along this line, an extension to a random
effects model to capture unobserved heterogeneity in network connectivity is desirable. Another
extension is to consider a dynamic network model where changes in network structure or connection
strength are captured. Furthermore, we can consider identifying the direction between nodes to
construct directed acyclic networks. With regard to the clinical utility of network connections, we
can provide the estimated network connections when a new patient is coming and further assign the
patient to one of the connectivity-based clusters by calculating the distance of the subject’s network
connections to centroid points of the clusters. The methodology introduced in Chapter 5 can also
be used to integrate information from different modality of biomarkers, such as genetic variants and
gene expressions. The current application of symptom networks is based on observational data.
When interventional data is available, personalized symptom network can also inform treatment
effects on each symptom.
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Appendix A
Appendix to Chapter 2
A.1 R-package
R-package APML0 contains R codes to perform all the methods considered in the simulation,
including penalties of Lasso, Enet, Net and ANet for both linear regression and Cox model. Most
intensive computation codes were written in C++ and integrated to R codes using R-package Rcpp
(Eddelbuettel et al., 2011). R-package APML0 is available upon request, and will be uploaded to
CRAN.
A.2 Additional Simulation Studies to Compare with ADMM
In additional simulation studies, we varied the distributions of covariates. We constructed X in
independent blocks, where each block consisted of five covariates and 15 covariates from three
blocks had non-zero effects on the outcome. Covariates from the first non-zero effect block followed
standard normal distribution and the covariates within the block were correlated with a correlation
of 0.5. In the second block, covariates followed normal distribution with mean 0 and variance 1.5,
and the variables within the block were correlated with a correlation of 0.5. In the third block,
covariates followed noncentral t-distribution with noncentral parameter 2 and degrees of freedom
4, and the variables within the block were independent with each other. We considered sample size
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n = 200 with various numbers of covariates.
Table A1 summarizes these simulation results. It can be seen that APM-L0 much outperforms
the commonly used `1-type methods based on cross validation of the partial likelihood (L-CVpl)
in terms of both estimation accuracy and selection performance for all cases when covariates have
different distributions. The improvement is substantial with a smaller SSE, comparable TP, much
less FP and a higher C-index (especially when p = 10, 000 with Anet penalty). ANet still performs
the best similar to the scenario when the distribution of covariates is the same.
Table A1: Comparison of the estimation and selection performance for Cox model based on APM-
L0 and existing `1-type methods for penalties ANet, Net, Enet and Lasso when covariates have
different distributions.
SSE1 C-index2 TP3 FP4
CVpl APM-L0 CVpl APM-L0 CVpl APM-L0 CVpl APM-L0
n = 200, p = 50
ANet 2.01 0.90 0.915 0.918 15.0 15.0 24.4 0.5
Net 2.74 0.91 0.904 0.909 15.0 15.0 22.9 0.3
Enet 2.75 0.93 0.904 0.909 15.0 15.0 23.0 0.3
Lasso 2.89 1.22 0.905 0.909 15.0 15.0 19.2 0.4
n = 200, p = 1000
ANet 10.56 3.42 0.826 0.859 14.8 14.5 163.3 0.7
Net 20.73 13.64 0.710 0.727 12.0 12.0 47.5 2.6
Enet 20.46 12.37 0.710 0.730 12.1 12.3 46.3 1.9
Lasso 19.49 11.50 0.709 0.730 11.8 12.1 42.1 1.3
n = 200, p = 10000
ANet 24.46 15.09 0.657 0.733 7.3 11.3 88.0 0.8
Net 26.48 24.95 0.645 0.659 5.2 4.5 27.1 2.7
Enet 26.50 25.34 0.639 0.642 4.9 3.8 22.6 3.1
Lasso 26.54 25.81 0.634 0.631 4.1 2.9 14.0 2.7
1SSE: Sum of squared error; 2C-index: Concordance index; 3TP: Number of true positive
covariates; 4FP: Number of false positive covariates.
APM-L0 uses surrogate parameters similar to the proximal splitting based algorithms (Com-
bettes and Pesquet, 2011) (ADMM algorithm is a special case). To see the difference with ADMM,
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first note that ADMM implemented in Boyd et al. (2011) optimizes the following
−n−1l(β) + ρ‖θ‖1, subject to
p∑
j=1
(βj − θj)2 ≤ c. (A.1)
However, APM-L0 replaces the `1-norm of θ in the above objective function by an `0-penalty, and
uses a general sparsity inducing penalty function φj(·) to bound the difference between θ and β
instead of restricting to a quadratic function (see also (2.2)). There is no existing literature on
using ADMM to handle `0-norm. For implementation, APM-L0 transforms the constrained form
(2.2) to its Lagrange form (2.3) as
(β,θ) = arg min
β,θ
−n−1l(β) + ρ‖θ‖0 + λ
p∑
j=1
φj(|βj − θj |), (A.2)
and simultaneously selects tuning parameters (λ, ρ) based on cross-validation. In contrast, ADMM
determines the step sizes of update functions (the equivalence of tuning parameters) by directly solv-
ing Lagrange equations instead of choosing them in a data-adaptive fashion from cross-validation.
Since ADMM uses `1-penalty for θ, we compared it to APM-L0 with Lasso penalty. The
simulation settings are as the same as in Section 4. We evaluated different values of the tuning
parameter given at 0.01, 0.05, 0.1, 0.5, 1.0, 5.0, 10.0, and 20.0. Table A2 summarizes the results of
ADMM under a linear regression model. Comparing to results of APM-L0 in Table 2.1, we can see
that APM-L0 has a smaller SSE, comparable TP and much smaller FP. For p = 50, both ADMM
and APM-L0 can correctly choose all true covariates, but APM-L0 selected more than 20 times
fewer FP than ADMM. When p = 10, 000, ADMM selected more TP variables, but at the price
of many more FPs. The number of iterations required for ADMM to converge can be more than
1, 000, and thus the computational speed is much slower than APM-L0 in some scenarios.
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Table A2: Estimation and selection performance of ADMM with fixed λ for linear regression.
n = 200, p = 50 n = 200, p = 1000 n = 200, p = 10000
SSE1 TP2 FP3 SSE1 TP2 FP3 SSE1 TP2 FP3
0.01 0.54 15.00 34.26 4.27 14.98 223.70 21.55 10.98 388.95
0.05 0.55 15.00 32.75 3.13 14.99 197.00 16.57 11.38 224.83
0.10 0.55 15.00 31.07 2.68 14.99 179.15 14.55 11.32 179.15
0.50 0.51 15.00 26.67 2.57 15.00 140.85 14.36 11.32 130.25
1.00 0.43 15.00 24.94 2.71 14.99 132.88 14.77 11.04 119.07
5.00 0.33 15.00 16.14 2.41 14.98 111.08 14.41 10.57 85.41
10.00 0.40 15.00 8.58 2.35 15.00 90.15 14.59 9.11 30.97
20.00 0.97 15.00 2.79 2.52 14.98 43.34 19.04 4.73 0.46
1SSE: Sum of squared error; 2TP: Number of true positive covariates; 3FP: Number of false
positive covariates.
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Appendix B
Appendix to Chapter 3
B.1 Detailed Parameter Updates in the Algorithm
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r 6=s α̂jkrXir)Mij). The initial
values of σ̂2εj are obtained by taking the first partial derivative of ln(ζ,α,σ
2) with respect to σ2εj .






















B.2 Detailed Simulation Settings
In Setting 1 and 2, we simulated covariates Xi independently from a standard normal distri-
bution. In Setting 1, we set common σ2εj = σ
2
ε = 0.2 for j = 1, ..., p. We assumed that four
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pairs of biomarkers are connected while the others are conditionally independent. The matrix
(αjk)j>k is a q × p(p−1)2 matrix. Each column represents one pair of biomarkers. We set col-
umn 1 of the matrix to be (−0.5,−1,−1.5, 0, ..., 0)T , column 5 to be (−1,−0.5,−1.5, 0, ..., 0)T ,
column 8 to be (1.5,−0.5, −1, 0, ..., 0)T , column 10 to be (−0.5,−1.5, 1, 0, ..., 0)T , and the remain-
ing columns all zeros. Column 1, 5, 8, 10 represent αjk for (j, k) ∈ {(1, 2), (2, 3), (3, 4), (4, 5)}
when p = 5, represent αjk for (j, k) ∈ {(1, 2), (1, 6), (1, 9), (2, 3)} when p = 10, and represent αjk
for (j, k) ∈ {(1, 2), (1, 6), (1, 9), (1, 11)} when p = 20. The matrix (ζj) is a q × p matrix. We set
ζ1 = (0.5, 1, 1.5, 0, ..., 0)
T , ζ2 = (1, 0.5, 1.5, 0, ..., 0)
T , ζ3 = (−1.5, 1, 0.5, 0, ..., 0)T and ζj = 0 for
j = 4, ..., p. We generated outcome from Yi = Xi1 + 2Xi2 + Mi1 + 3Mi2 + Wi,s1r1 + 2Wi,s5r5 + εi,
where Xi, M i, and W i are standardized and εi ∼ N(0, 1). Wi,s1r1 is the 1st mutual information
where (s1, r1) = (1, 2) for p = 5, 10, 20. Wi,s5r5 is the 5th mutual information where (s5, r5) = (2, 3)
for p = 5, and (s5, r5) = (1, 6) for p = 10, 20.
In Setting 2, we set one third of σ2εj to be 0.15, one third to be 0.2, and one third to be 0.25. For
example, σ2εj = 0.15 for j ∈ {1, 4, 7, 10}, σ
2
εj = 0.2 for j ∈ {2, 5, 8} and σ
2
εj = 0.25 for j ∈ {3, 6, 9}
when p = 10. In matrix (αjk)j>k, we set column 1 to be (−0.5,−1,−1.5, 0, ..., 0)T , column 5 to be
(1,−0.5,−0.5, 0, ..., 0)T , column 8 to be (−1, 1,−1, 0, ..., 0)T , column 10 to be (−1,−2, 0.5, 0, ..., 0)T ,
and the remaining columns all zeros. The settings for (ζj) and outcome are as the same as in Setting
1.
In Setting 3, we included a binary covariate. The second covariate Xi2 follows a Bernoulli distri-
bution, Bernoulli(0.5) and the other covariates follow standard normal distribution independently.
We set heterogeneous σ2εj as the same as in Setting 2. The settings for (αjk)j>k, (ζj), and outcome
are as the same as in Setting 1.
In Setting 4, we considered (p, q) = (5, 3), (p, q) = (10, 5), and (p, q) = (20, 10). The settings
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for (αjk)j>k, (ζj), σ
2
εj and outcome are as the same as Setting 1.
In Setting 5, we considered n = p = 100 with q = 5. The settings for (αjk)j>k, (ζj), σ
2
εj and
outcome are as the same as Setting 1.
B.3 Additional Simulation Results
Table B1: Estimation and Selection Performance of Simulations in Setting 3.
n = 500 n = 1000
SSE1 TP2 FP3 TN4 FN5 MCC6 SSE1 TP2 FP3 TN4 FN5 MCC6
p = 5, q = 5
1st stage ζ 0.465 8.95 1.49 14.51 0.05 0.877 0.212 8.99 1.26 14.74 0.01 0.898
α 0.368 12.00 2.57 35.43 0.00 0.876 0.139 12.00 1.65 36.35 0.00 0.917
2nd stage γ 0.126 2.00 0.61 7.39 0.00 0.841 0.036 2.00 0.43 7.57 0.00 0.883
β 0.026 2.00 0.50 2.50 0.00 0.816 0.008 2.00 0.46 2.54 0.00 0.830
η 0.016 2.00 0.49 2.51 0.00 0.820 0.006 2.00 0.47 2.53 0.00 0.826
p = 10, q = 10
1st stage ζ 1.091 8.51 2.15 88.85 0.49 0.855 0.489 8.99 1.45 89.55 0.01 0.920
α 0.864 11.73 4.17 433.83 0.27 0.845 0.382 11.99 2.59 435.41 0.01 0.904
2nd stage γ 0.583 1.96 1.01 41.99 0.04 0.794 0.119 2.00 0.95 42.05 0.00 0.814
β 0.090 2.00 1.55 6.45 0.00 0.674 0.025 2.00 1.09 6.91 0.00 0.748
η 0.053 2.00 1.48 6.52 0.00 0.684 0.014 2.00 1.14 6.86 0.00 0.739
p = 20, q = 20
1st stage ζ 2.168 8.08 4.36 386.64 0.92 0.757 1.084 8.88 4.76 386.24 0.12 0.796
α 1.833 11.50 7.30 3780.70 0.50 0.765 0.828 11.99 4.77 3783.23 0.01 0.845
2nd stage γ 0.889 1.92 1.45 186.55 0.08 0.736 0.200 2.00 1.21 186.79 0.00 0.787
β 0.250 2.00 2.92 15.08 0.00 0.584 0.063 2.00 2.79 15.21 0.00 0.594
η 0.045 2.00 3.13 14.87 0.00 0.568 0.012 2.00 2.23 15.77 0.00 0.644
1SSE: Average sum of squared error across 100 simulations; 2TP: Average number of true positive
parameters across 100 simulations; 3FP: Average number of false positive parameters across 100
simulations; 4 TN: Average number of true negative parameters across 100 simulations; 5 FN: Average
number of false negative parameters across 100 simulations; 6 MCC: Matthews correlation coefficient
B.4 Additional Results for Analysis of PREDICT-HD
B.4.1 Net Reclassification Improvement of Imaging Model
A measure to quantify the improvement in prediction performance of a new model with additional
predictors as compared to an existing model is the net reclassification improvement (NRI) for
predicting conversion to HD diagnosis. The continuous NRI statistic (Pencina et al., 2011) is
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p = 5, q = 3 p = 10, q = 5 p = 20, q = 10 p = 5, q = 3 p = 10, q = 5 p = 20, q = 10
Setting 4, n=500 Setting 4, n=1000
Figure B1: Frequency of edges selected in the first stage across 100 simulations in Settings 1-4.
Edge width is proportional to the number of times an edge was identified. Black: true positive
edges; Grey: false positive edges. Actual edges are the black lines.
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Table B2: Estimation and Selection Performance of Simulations in Setting 4.
n = 500 n = 1000
SSE1 TP2 FP3 TN4 FN5 MCC6 SSE1 TP2 FP3 TN4 FN5 MCC6
p = 5, q = 3
1st stage ζ 0.269 8.99 0.57 5.43 0.01 0.921 0.111 9.00 0.44 5.56 0.00 0.940
α 0.148 12.00 2.36 15.64 0.00 0.852 0.052 12.00 1.95 16.05 0.00 0.876
2nd stage γ 0.043 2.00 0.26 7.74 0.00 0.925 0.016 2.00 0.29 7.71 0.00 0.917
β 0.006 2.00 0.14 0.86 0.00 0.897 0.003 2.00 0.15 0.85 0.00 0.889
η 0.020 2.00 0.44 2.56 0.00 0.836 0.009 2.00 0.47 2.53 0.00 0.826
p = 10, q = 5
1st stage ζ 0.528 8.95 1.78 39.22 0.05 0.890 0.270 9.00 1.30 39.70 0.00 0.920
α 0.368 12.00 2.03 210.97 0.00 0.920 0.218 12.00 2.16 210.84 0.00 0.916
2nd stage γ 0.083 2.00 0.49 42.51 0.00 0.891 0.025 2.00 0.30 42.70 0.00 0.929
β 0.008 2.00 0.44 2.56 0.00 0.836 0.003 2.00 0.22 2.78 0.00 0.914
η 0.041 2.00 1.34 6.66 0.00 0.706 0.010 2.00 1.01 6.99 0.00 0.762
p = 20, q = 10
1st stage ζ 1.654 8.76 3.70 187.30 0.24 0.818 0.440 8.99 2.51 188.49 0.01 0.878
α 1.133 12.00 5.05 1882.95 0.00 0.838 0.245 12.00 1.35 1886.65 0.00 0.948
2nd stage γ 0.061 2.00 0.4 187.60 0.00 0.912 0.022 2.00 0.25 187.75 0.00 0.942
β 0.009 2.00 0.96 7.04 0.00 0.771 0.005 2.00 0.95 7.05 0.00 0.773
η 0.024 2.00 2.26 15.74 0.00 0.641 0.013 2.00 1.98 16.02 0.00 0.669
1SSE: Average sum of squared error across 100 simulations; 2TP: Average number of true positive
parameters across 100 simulations; 3FP: Average number of false positive parameters across 100
simulations; 4 TN: Average number of true negative parameters across 100 simulations; 5 FN: Average


























































































































































































Figure B2: Frequency of edges selected in the first stage across 100 simulations in Setting 5. Edge
width is proportional to the number of times an edge was identified. Black: true positive edges;
Grey: false positive edges. Actual edges are the black lines.
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Table B3: Estimation and Selection Performance of Simulations in Setting 5 with n = p = 100.
n = p = 100, q = 5
SSE1 TP2 FP3 TN4 FN5 MCC6
1st stage ζ 8.009 3.9 2.38 488.62 5.10 0.512
α 5.196 11.18 7.5 24730.5 0.82 0.747
2nd stage γ 1.114 1.73 0.32 4945.68 0.27 0.854
β 0.130 2 0.25 2.75 0.00 0.903
η 0.631 1.96 3.87 94.13 0.04 0.562
1SSE: Average sum of squared error across 100 simulations; 2TP: Average number of true positive
parameters across 100 simulations; 3FP: Average number of false positive parameters across 100
simulations; 4 TN: Average number of true negative parameters across 100 simulations; 5 FN: Average
number of false negative parameters across 100 simulations; 6 MCC: Matthews correlation coefficien











































































































Figure B3: Identified paths through brain connections. Blue line: covariate effect directly on
outcome; Red line: covariate effect through network connections; Orange node: covariate; Purple
node: brain connection (intermediate variable); Green node: outcome. Node size is proportional
to the degree of the node (for node with directed connection, the degree is the sum of outdegree
and indegree).
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Table B5: Estimated total effect (L2 norm) of covariates on network connections in the first stage










Stroop color naming 0.457 1.409
Stroop word reading 0.483 1.858
Stroop inference 0.122 1.614
Dual verbal working memory total 0.883 1.749
Hopkins verbal learning test delayed recall 0.400 1.772
Verbal fluency total correct 0.327 1.844
Hopkins verbal learning test total 0.417 1.289
Smell identification test percent 0.505 1.907
Gray matter volume total 0.288 1.816
White matter volume total 0.426 1.766
1: L2 norm of all the estimated connection coefficients for each covariate.
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Table B6: 22 identified cortical connections in PREDICT-HD study.























1Estimated effect size: Estimated coefficient in the refitted linear regression model (second stage outcome
model).
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defined as
NRI = NRIe +NRIē,
where NRIe quantifies the amount of correct reclassification among converters and NRIē quantifies
that among non-converters. Specifically, NRIe = P (Ŷi1 > Ŷi0|Di = 1) − P (Ŷi1 < Ŷi0|Di = 1) and
NRIē = P (Ŷi1 < Ŷi0|Di = 0)− P (Ŷi1 > Ŷi0|Di = 0), where Di is an indicator of HD diagnosis, Ŷi1
and Ŷi0 are the estimated rate of change in motor score based on the new model and the existing
model in the test set, respectively. A positiveNRI indicates that the new model improves prediction
performance compared to the existing model. The average NRI based on the testing data is 0.36
(95% CI: [0.03, 0.70], p < 0.05). In addition, the average NRIe was 0.24 and the average NRIē was
0.12. The imaging biomarker model improves the reclassification rate for converters more than for
non-converters. These results demonstrate the gain of predictive power of imaging biomarkers and
cortical network connections in addition to standard covariates.
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Appendix C
Appendix to Chapter 5
C.1 Reducing Computational Burden
The computation of the posterior expectations of connection indicators E(Bijk|Mij , Di) and
E(BijkBijk′ |Mij , Di) increases exponentially with the graph size p. There are 2p−2 combinations
of summations involved in P (Bijk,Mij |Di) for each subject i and an edge between nodes j and k
among p ∗ (p− 1) edges in total.
C.1.0.1 Pruning Based on Posterior Expectation
Motivated by automatic relevance determination (Wipf and Nagarajan, 2008), we treat the es-
timated posterior expectation E(Bijk|Mij , Di) from the previous iteration in EM algorithm as a
tuning parameter to further prune bijk and reduce the combinations of summations in computation.
In each EM iteration, we set bijk = 1 if E(Bijk|Mij , Di) estimated from the previous iteration is
greater than an upper threshold, and set bijk = 0 if the estimated E(Bijk|Mij , Di) is smaller than
a lower threshold. The combinations are then restricted only to those bijk’s with E(Bijk|Mij , Di)
within the interval defined by two thresholds.
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C.1.0.2 Approximation of the Posterior Expectation
The pruning approach discussed above (Section C.1.0.1) still calculates the summations directly.
We propose an approximation to bypass direct sum to speed up the computation. Note that the
summation involves the form of exp(−u2). Our goal is to compute the function exp(−u2) with a
fast, non-iterative, non Monte-Carlo algorithm. To this end, we approximate exp(−u2) by using
the mixture of exponential distributions exp(−λu) uniformly in a range [-A, A] For ui in [-A, A], let
yi = exp(−u2i ) . Let ᾰi = (exp(−λ1ui), · · · , exp(λKui))T be a vector of K basis functions. We use
least squares approximation yi = ᾰiζ+ei to compute basis coefficients ζ. We can then approximate
any value of exp(−u20) by ᾰu0 ζ̂. The mean squared error of such approximation is about 1× 10−10
when using the mixture exponentials we set in Section 5.3.1.
Once we have obtained ζ̂, we can use it to calculate an approximation of




































(1 + eaj−λkcj ).
Therefore we can approximate the posterior expectations by
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(Mij − bβTjkXiMik)βTjlXiMil + log(
pijl
1−pijl ), l 6= j, k, and
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(Mij − bβTjkXiMik − b′βTjk′XiMik′)βTjlXiMil +
log(
pijl
1−pijl ), l 6= j, k, k
′.
This approximation does not require the computation of an exponential number of terms in the
summation. Instead, compute the posterior expectation using a basis expansion and least squares
regression to obtain basis coefficients. The computational burden reduces from exponential in the
graph size to polynomial.
C.2 Identified Connections in Real Data Application
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Table C1: Identified Cortical Connections in TRACK-ON Study.
Connections Proposed Method EBIC glasso DTI
(22 edges) (12 edges) (8 edges)
R.isthmuscingulate/R.precuneus X X
R.cuneus/R.lateraloccipital X X
L.precuneus/R.paracentral X X
L.precuneus/R.pericalcarine X X
R.isthmuscingulate/L.paracentral X X
L.precuneus/R.precuneus X X
R.isthmuscingulate/R.pericalcarine X
L.isthmuscingulate/L.paracentral X
R.cuneus/L.precuneus X
R.precuneus/L.paracentral X
R.lateraloccipital/R.isthmuscingulate X
R.lateraloccipital/R.pericalcarine X
R.supramarginal/R.paracentral X X
R.cuneus/R.paracentral X
R.supramarginal/R.pericalcarine X
R.lateraloccipital/L.precuneus X
R.supramarginal/L.isthmuscingulate X
R.supramarginal/L.paracentral X
R.lateraloccipital/L.isthmuscingulate X
R.supramarginal/R.precuneus X X
R.cuneus/R.supramarginal X
R.lateraloccipital/R.supramarginal X X
L.precuneus/R.supramarginal X X
R.cuneus/R.precuneus X
R.cuneus/R.pericalcarine X
L.precuneus/L.paracentral X
R.paracentral/R.precuneus X
R.paracentral/L.paracentral X
R.precuneus/R.pericalcarine X
L.paracentral/R.pericalcarine X
R.precuneus/L.isthmuscingulate X
L.isthmuscingulate/R.pericalcarine X
